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ABSTRACT 
We initially assessed the characteristics of stroke development in Dahl salt-
sensitive rats (Dahi-SS). Dahi-SS developed high blood pressure (BP) when fed 
a high salt diet (8.7% NaCI) from weaning and a 50% mortality after being fed the 
diet for 4 to 5 weeks. Prior to death, Dahi-SS exhibited behavioural symptoms 
(convulsions, seizures, paralysis and stupor) consistent with the possible 
development of stroke. However, unlike true stroke, the behavioural 
dysfunctions observed were not associated with cerebral ischemia and occurred 
in the virtual absence of cerebral hemorrhage. An investigation of the 
cerebrovascular pathology indicated a breakdown in the integrity of the blood 
brain barrier and fluid movement into the extravascular space (edema). It was 
concluded that Dahi-SS best represents a model of hypertensive encephalopathy 
(HE). In humans HE is produced by brain edema as a result of hypertension in 
the absence of cerebral ischemia or hemorrhage. It produces convulsions, 
confusion, and stupor and can result in death. The latter symptoms are 
consistent with those observed in Dahi-SS fed high salt. 
Antihypertensive intervention (captopril) was ineffective in lowering blood 
pressun3 or reducing the incidence of mortality. Non-cerebral organ failure was 
also evident prior to death as demonstrated by kidney dysfunction associated 
with increased plasma creatinine, urea, urinary protein excretion and decreased 
plasma albumin levels. 
II 
In subsequent experiments we tested the hypothesis that a breakdown in 
the ability to autoregulate cerebral blood flow (CBF) may contribute to the 
development of HE in Dahi-SS fed high salt. Such a defect could promote 
cerebrovascular overperfusion and elevate microvascular blood pressure, 
alterations that would facilitate blood brain barrier disruption and HE 
development. Laser Doppler techniques were used to assess the changes in 
relative CBF with varying BP in the perfusion domain of the middle cerebral 
arteries (MCA's). Dahi-SS fed 8.7% NaCI for 1 week exhibited an ability to 
autoregulate near constant CBF up to an upper mean BP of 168 mmHg. Two 
thirds of the rats lost the ability to autoregulate CBF after they were fed a high 
salt diet: for 3 weeks at a time prior to the development of HE. These rats 
exhibited a linear increase in CBF with elevations in arterial pressure. The 
characteristics of the CBF autoregulatory curves suggested that CBF 
autoregulation was lost under conditions of cerebrovascular constriction. 
In other experiments we assessed the hypothesis that the loss of CBF 
autoregulation in the MCA perfusion domain of Dahi-SS was associated with an 
inability of the MCA's to elicit pressure dependent constriction (PDC). PDC is an 
important mechanism involved in promoting CBF autoregulation. Elevations in 
BP promote cerebrovascular constriction, which raises vascular resistance to 
blood flow. This counteracts the potential elevation in CBF enabling CBF to 
remain constant under conditions of elevated BP. Isolated MCA's from 
asymptomatic Dahi-SS exhibited constriction in response to elevated pressure 
Ill 
and protein kinase (PKC) activation (a signaling intermediate for PDC in MCA's). 
In addition the MCA's vasodilated in an endothelium dependent manner in 
response to bradykinin. These functions were lost in the MCA's of Dahi-SS with 
HE. MCA's from post-HE Dahi-SS that were unable to constrict to pressure 
lacked the ability to constrict in response to PKC activation via phorbol esters. 
They exhibited high levels of basal tone and no response to the endothelial 
specific vasodilator, bradykinin. The loss of PDC in MCA's of Dahi-SS preceded 
the deve~lopment of HE and occurred in asymptomatic rats fed high salt for 3 
weeks at a time when CBF autoregulation was lost. 
It was concluded that defects in the ability of the cerebrovasculature to 
autoregulate CBF in conjunction with the development of renal dysfunction could 
contribute to the development of HE in Dahi-SS fed high salt. Cerebrovascular 
PDC is thought to play an important role in facilitating CBF autoregulation. The 
loss of this function could contribute to a loss of CBF autoregulation under 
hypertensive conditions. This could increase cerebrovascular pressures and 
promote overperfusion in the brain, leading to the development of cerebral 
edema and HE. The development of HE could be further augmented by a 
decreas~~ in plasma oncotic pressure promoted by the loss of plasma proteins 
due to the occurrence of proteinuria. The presence of a dysfunctional PKC 
system in the vascular smooth muscle of MCA's sampled from Dahi-SS with HE 
could contribute to the loss of PDC in the arteries. 
IV 
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CHAPTER 1 
LITERATURE REVIEW 
1.1 ETIC>LOGY OF STROKE 
Stroke is defined as a neurological dysfunction (behavioural, motor and 
cognitive) produced by ischemia and/or hemorrhage within the brain. It is one of 
the most prevalent diseases promoting mortality and morbidity in western 
society. 
Ischemic stroke is promoted by an interruption of blood flow through the 
cerebrovasculature. Blood flow interruption can be precipitated by blockages 
(sclerotic plaques or emboli) within the cerebral vessels or carotid arteries or as a 
result of an interruption in blood flow to the brain promoted by decreases in 
cardiac output (Caplan, 2000). The extent of brain damage that occurs is 
dependemt on the length of time that blood flow is compromised. Neurological 
deficits will vary depending on location of ischemia. 
Hemorrhagic stroke can be subdivided into intracerebral (bleeding directly 
into the brain) or subarachnoid (bleeding along the surface of the brain within the 
subarachnoid space). The time course is different for each subtype of 
hemorrhage. Subarachnoid hemorrhage develops quickly. Blood released from 
aneurysms of surface arteries fills the subarachnoid space around the brain. This 
raises intracranial pressure and promotes regional ischemia due to vascular 
compression and cerebrovascular constriction (Davis and Robertson, 1991). The 
compression of cranial nerves can also result in a disruption of normal neural 
2 
pathway activity (Caplan, 2000). Typically, intracerebral hemorrhage develops 
more gradually in comparison to subarachnoid hemorrhage. Extravasation of 
blood from intracerebral arterioles and capillaries creates a situation where blood 
accumullates within the extravascular space of the brain (Caplan, 2000). In 
addition to blood, other substances (i.e. glutamate, serotonin, fatty acids, 
lysosomal enzymes and free radicals) that leak into the parenchyma from the 
lesion alter vascular integrity and reactivity (Davis and Robertson, 1991 ). The 
resultant effects may include changes in endothelial integrity, cell morphology 
and cell energy metabolism (Baethmann eta/., 1980) as well as the production of 
cerebral vasospasm (Sobey & Faraci, 1998; Sobey, 2001). There are certain 
situations, such as during cocaine use, where intracerebral hemorrhage can 
occur rapidly (Conway & Tamargo, 2001 ). 
In addition to the occurrence of ischemic and hemorrhagic stroke, 
hypertension is associated with other forms of cerebral pathology such as 
hypertensive encephalopathy (HE). HE is often produced by a sudden rise in 
blood pressure that promotes widespread edema formation and the loss of 
cerebral blood flow autoregulation (CBF) (Dinsdale, 1982). The loss of CBF 
autoregulation promotes overperfusion of the vasculature straining the integrity of 
the blood brain barrier and resulting in increased movement of fluid (edema) and 
possibly blood into the extravascular space (Skinhoj & Strandgaard, 1973; 
Strandgaard eta/., 1974). Brain edema produces a rise in intracranial pressure 
causing neurological abnormalities to develop (Byrom, 1969). 
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1.2 ROLE OF HYPERTENSION IN STROKE DEVELOPMENT 
There is a strong correlation between the rise in blood pressure and the 
incidence of ischemic and hemorrhagic stroke. Hypertension has been 
suggest~ed to be the single most prevalent modifiable risk factor associated with 
stroke development (Strandgaard, 1996). Consistent with this, antihypertensive 
treatments significantly attenuate the onset of stroke development (Collins et a/., 
1990; MacMahon, 1990). 
1.2.1 HE!morrhagic Stroke and Hypertension 
Hemorrhagic stroke represents 10-15% of all stroke cases (Thrift et a/., 
1995). !Intracerebral hemorrhage is the most common form of hemorrhagic 
stroke. The occurrence of hypertension is more closely related to hemorrhagic 
than ischemic stroke and antihypertensive treatments reduce the risk of this type 
of strokE~ development. (Gebel & Broderick, 2000). The likelihood of intracerebral 
hemorrhagic stroke development is 2 to 6 times greater in hypertensive 
individuals versus normotensive individuals (Okada eta/., 1976; Lin eta/., 1984; 
Kagan eta/., 1985; Brott eta/., 1986). 
Although human epidemiological studies have confirmed that hypertension 
is a key risk factor promoting the development of hemorrhagic stroke, eight 
percent of stroke due to intracerebral hemorrhage occurs without elevated blood 
pressure. Eight percent of intracerebral hemorrhage occurs in individuals with 
normal pressure (del Zoppo & Mori, 1992). Patients show an increase in the 
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vulnerability to develop hemorrhagic stroke during anticoagulant treatment. There 
are also congenital and acquired factor deficiencies (thrombocytopenia and 
thrombocytopathic) that increase the likelihood of developing cerebral 
hemorrhage (Hart eta/., 1995). Arteriovenous malformations (enlarged vessels), 
cavernous angiomas (fibrous deposits in vessel walls) and cerebral tumors 
increase~ the risk cerebral hemorrhage (Gebel & Broderick, 2000). 
1.3 ANIMAL MODELS OF STROKE 
A.lthough the link between hypertension and stroke development is 
apparent in humans there are few animal models that develop stroke 
spontaneously during hypertension. Early studies evaluating stroke development 
tried to mimic stroke, either by occluding blood vessels projecting into the brain 
(Bederson et a/., 1986; Grabowski et a/., 1988) or by injecting blood into the brain 
ventricles (Batton & Nardis, 1987). The emphasis of these studies was on the 
observation of the secondary changes in cerebral pathology associated with 
these interventions rather than the underlying mechanisms promoting stroke 
development. Stroke has been inconsistently noted in Goldblatt renal forms of 
hypertension (Byrom, 1969). Predictable and consistent stroke development has 
been de~scribed in Kyoto Wistar stroke prone spontaneously hypertensive rats 
(SHRsp) (Smeda, 1989, 1992) and Dahl salt sensitive rats (Dahi-SS) (von 
Lutterott:i eta/., 1992; Lin eta/., 1999; Zhang eta/., 1999). 
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1.4 DE:VELOPMENT OF THE KYOTO WISTAR STROKE PRONE 
SPONTANEOUSLY HYPERTENSIVE RAT 
Predicable, spontaneous stroke development occurs in SHRsp (Yamori et 
a/., 1984). Okamoto and Aoki (1963) selectively inbred Kyoto Wistar 
normotensive (WKY) rats that exhibited above average (> 150 mmHg) blood 
pressure~s. The selective inbreeding of these rats produced offspring in which 
high systolic BP (>180 mmHg) was observed by 13 weeks of age (normal 
systolic BP in a rat is <150 mmHg). This strain of rat was named the Kyoto 
Wistar spontaneously hypertensive rat (SHR). SHR developed a low incidence of 
stroke however by selective inbreeding of the offspring of the few SHR that 
exhibited stroke another substrain of SHR defined as the SHRsp was developed 
(Okamoto, 1974). Unlike SHR, which had systolic blood pressures of about 180 
mmHg, SHRsp developed more robust hypertension (240 mmHg) and when they 
were fed an appropriate diet, a 100% incidence of stroke occurred prior to death 
(Yamori eta/., 1984). 
1.4.1 Role of Diet in the Stroke Development of SHRsp 
Diet was shown to play a crucial role in promoting stroke development in 
SHRsp. SHRsp fed the regular rat chow (Nihon Clea or Purina rat chow), lived 
between 31 and 41 weeks and developed a low incidence of stroke 
(30%)(0kamoto eta/., 1974; Yamori eta/., 1984). However, when the regular diet 
was substituted with a Japanese, Funahashi-sp diet, the incidence of stroke 
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increase~d to 80% (Yamori eta/., 1984). The only observable difference between 
the two diets was a lower protein content (18% compared to 22% in Purina Rat 
Chow). Wexler (1983) suggested that the origin of the protein within the diet 
(fish-Funahasi versus plant-Purina) had an important impact on stroke 
development in SHRsp. Subsequently, a North American-Japanese style diet (a 
reproduction of the Funahasi-sp diet; produced by Ziegler Brothers) was 
develop1ed and supplemented with 4% NaCI (Smeda, 1989). The latter diet 
produced a 100% incidence of hemorrhagic stroke in SHRsp by 16 weeks of age 
(Smeda, 1989). 
1.4.2 BE~havioural Symptoms of Stroke Development in SHRsp 
The characteristics of stroke development in SHRsp fed a Japanese style 
diet containing 4% NaCI have been previously outlined in detail (Smeda, 1989, 
1992). The onset of stroke development consisted of repetitive convulsive 
movements of the upper extremities (noticeably forelimbs and head). 
Subsequently, the animals underwent periods of immobility and marked lethargy 
coupled with cessation of grooming. The animals adopted a posture, described 
as "kan!~aroo like", in which they remained motionless with their legs extended 
under their bodies and died on average 1.5 weeks after the first behavioural 
signs of stroke. 
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1.4.3 ce,rebral Pathology and Hemorrhagic Stroke in SHRsp 
Okamoto eta/. (1974) demonstrated the presence of fibrinoid necrosis and 
hyaline deposits in the cerebral vessel walls in SHRsp with stroke and observed 
brain hemorrhages and edema. An analysis of the pathological changes in the 
brains of SHRsp with stroke was conducted by Ogata eta/. (1981). In this study 
the brains of 5 SHRsp were serially sectioned for histological analysis. The 
affected vessels in the parenchyma were thickened due to fibrinoid deposits and 
most vessels showed stenosis or thrombotic occlusion. Vessels of the 
subarachnoid layer displayed proliferation of the arterial layer. Tissue injury 
included cyst formation in the white matter and rarefaction of the neuropil (Ogata 
et a/., 11980). In a more complete microscopic examination 38 brains of old 
SHRsp (>30 weeks of age displaying neurological symptoms consistent with 
stroke development) showed that 31 exhibited cerebral lesions. Rarefaction of 
the neuropil and preservation of the neocortical neurons and adjacent white 
matter were observed in 29 brains. There was massive intracerebral 
hemorrhage of 3 brains and observations of old hemorrhages filled with 
macrophages in 13 brains (Ogata et a/., 1982). In more recent studies, 
intracerE~bral hemorrhages have been detected on one or both of the 
hemispheres of the cerebrum in SHRsp fed a Japanese-style diet supplemented 
with 4% NaCI in which behavioural symptoms of stroke were observed (Smeda, 
1989). Hemorrhages did not develop in the cerebellum, or the pons and medulla 
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regions of the brain. In addition, microhemorrhages were observed around the 
eyes of 1rats (Smeda, 1989). 
1.4.4 Alterations in the Renin-Angiotensin System and Stroke Development 
in SHR!:ip 
Recent studies evaluating stroke development in SHRsp have speculated 
that hyperactivity of the renin angiotensin system (RAS) may play a role in 
promoting the onset of stroke (Stier et a/., 1989; Stier et a/., 1991; Stier et a/., 
1993; Macleod eta/., 1997; Smeda eta/., 1999b). 
1.4.4.1 Overview of the Renin Angiotensin System 
The renin angiotensin system (RAS) regulates sodium and water balance, 
blood volume and arterial pressure within the body (Guyton, 1992). The main 
promoter in this cascade is renin, which is released into the circulation by the 
kidney and catalyzes the conversion of the poly-peptide angiotensinogen to 
angiotensin I (ANG 1). AI is then converted to angiotensin II (ANG II) via the 
angiotensin converting enzyme (ACE) (Guyton, 1992). 
R:enin is released from preglomerular arterioles, in response to changes in 
NaCI concentration and urine flow through the distal renal tubules and is 
controlled by the juxtaglomerular apparatus (comprised of the section of distal 
tubule that passes between the efferent and afferent arterioles of the 
glomerulus). Reductions in the urine concentration of NaCI and/or low urine flow 
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are detected by the macula densa, which stimulates the release of renin from the 
afferent arterioles. In addition, the stimulation of p-adrenergic receptors located 
on renal arterioles can also increase the release of renin (Reid et a/., 1978). 
There are also non-juxtaglomerular mechanisms stimulating the release of renin. 
In hydronephrotic kidneys (lack functional macula densa), lowering renal 
perfusion pressure still produces renin secretion (Scholz et a/., 1993) suggesting 
that barostatic control independent of the macula den sa exists. 
1.4.4.2 The Renin Angiotensin System, Angiotensin II and Hypertension 
Development 
There are two main ANG II receptor subtypes (AT1 and AT2), which are 
stimulatt3d by ANG II (Stroth & Unger, 1999). Most of the classic effects of blood 
pressurH and hypertension are mediated through the AT1 receptor and can be 
blocked by AT1 receptor antagonists such as losartan (Timmermans, 1999). The 
function of AT2 receptor activation is less clear but studies have indicated that 
AT2 recE3ptors may be involved in modifying proliferation in rat carotid arteries 
(Nakajima eta/., 1995) and apoptosis in cultured cells (Yamada eta/., 1996). 
ANG II has a profound impact on blood pressure. The stimulation of AT1 
receptors located on presynaptic sympathetic nerve terminals promotes the 
release of norepinephrine (NE) (Hughes & Roth, 1971 ). The release of NE acts 
on smooth muscle a1 and a2 receptors to produce vasoconstriction, thus 
Increasing vascular resistance to blood flow and blood pressure. Stimulation of 
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AT1 receptors in the adrenal gland by ANG II stimulates the release of 
aldosterone (Reid eta/., 1978; Weir & Dzau, 1999). Aldosterone is an antidiuretic 
hormone that facilitates the uptake of sodium and water from the urine into the 
blood. Sodium and water retention could lead to an increase in blood volume and 
cardiac output, which has the potential to raise blood pressure (Weir & Dzau, 
1999). 
A.NG II can also promote the maintenance of hypertension development 
by inducing structural alterations in the arteriolar vasculature (Hajdu eta/., 1991 b; 
Chillon c~ Baumbach, 1999). ANG II has been shown to increase smooth muscle 
cell division (Baumbach & Heistad, 1989). This could lead to the development of 
vascular hypertrophy (through increased vascular smooth cell multiplication and 
individual cell growth). An increase in wall thickness facilitates the maintenance 
of hypertension by increasing vascular contractile reactivity and vascular 
resistance to flow. Evidence supporting this was demonstrated in SHR. 
Treatment with angiotensin converting enzyme inhibitors or the AT1 receptor 
antagonist losartan normalized blood pressure and promoted a thinning of the 
cerebral vascular wall (Hajdu eta/., 1991b; Chillon & Baumbach, 1999). Other 
antihype~rtensive agents such as hydralazine can also normalize blood pressure 
in SHR but such treatment has no effect on vascular wall thickness (Hajdu et a/., 
1991a). 
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1.4.4.3 .Alterations in Renin Angiotensin System in SHRsp in Relation to 
Stroke !Development in SHRsp 
Plasma renin levels are increased with age in SHRsp (Volpe eta/., 1990; 
Camargo eta/., 1991; Gahnem eta/., 1994) and are higher in comparison to 
Kyoto VVistar normotensive control rats (Stier et a/., 1991; Kim et a/., 1992; 
Hubner et a/., 1995). Normally an increase in dietary salt would reduce the 
secretion of renin (Stier et a/., 1993). However, in SHRsp this produces a 
paradoxical situation where plasma renin levels are increased (Stier eta/., 1991 ). 
Substantial research has been conducted on SHRsp demonstrating that 
angiotensin converting enzyme inhibitors (ACEis which inhibit the conversion of 
ANG I to ANG II) retard the onset of stroke development. This often occurs in the 
absence of an antihypertensive effect (Stier et a/., 1989; Stier et a/., 1991 ; Stier 
et a/.,.1993; Macleod eta/., 1997). 
Steir et a/. (1989) studied SHRsp fed a stroke-prone diet supplemented 
with 1% NaCI in the drinking water. Enalapril treatment (15 mg/kg/day, in the 
drinking water) at 8 to 9 weeks of age produced a small hypotensive effect and 
retarded the onset of stroke-associated mortality from about 14 to 36 weeks of 
age. Captopril treatment (50mg/kg/day) produced a similar effect (Stier et a/., 
1991 ). A small reduction in blood pressure was observed between 9 and 11 
weeks of age and no stroke-associated mortality was observed up to 26 weeks of 
age. In other studies, the AT1 receptor antagonist losartan (1 0 mg/kg/day) 
produced similar effects to those observed with ACE I treatment (Stier et a/., 
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1993). No observable signs of stroke were observed up to 28 weeks of age 
whereas a 100% mortality was observed in untreated SHRsp by 14 weeks of 
age. 
The effects of ACEis or losartan can not be explained by the modest 
antihype!rtensive effects of the drugs. Stier eta/. (1989) found that the blockade 
of thrornboxane A2 synthesis by dazmegrel in SHRsp fed high salt produced 
similar antihypertensive effects to those observed during enalapril and captopril 
treatment. However, the onset of stroke was not altered. This suggested that 
blockade of RAS with ACEis or losartan in SHRsp retarded the onset of stroke 
development in a manner independent of any antihypertensive effect. In this 
regard, it was suggested that ANG II increased vascular damage in the 
cerebrovasculature by increasing neutrophil chemoattraction to the vascular 
endothelium and enhancing cerebrovascular fibrinoid necrosis, thus altering 
vasc~lar permeability (Stier eta/., 1989; Stier eta/., 1991). These alterations 
were su!ggested to facilitate the development of stroke in SHRsp fed high salt. 
R:ecent studies evaluated the anti-stroke effects of aldosterone 
suppression on stroke development in SHRsp fed a high salt diet (Japanese-
style diet supplemented with 4% NaCI). ACE inhibition with captopril 
(50mg/kg/day) reduced plasma aldosterone levels and delayed the onset of 
stroke (Macleod et a/., 1997). It was observed that the administration of 
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aldosterone (via osmotic mini pumps) into captopril treated rats negated the anti-
stroke effects of captopril allowing stroke development to occur (Macleod eta/., 
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1997). Administration of the mineralocorticoid deoxycorticosterone (instead of 
aldosterone) in captopril treated rat's mimiced the effects of aldosterone whereas 
treatment with the glucocorticoid dexamethasone did not. This suggested the 
anti-stroke effects produced by captopril may have occurred in the absence of 
any direct effect of ANG II and that the suppression of plasma aldosterone during 
captopril treatment was important in delaying the onset of stroke development in 
these rats. 
1.5 DEVELOPMENT OF THE DAHL SALT SENSITIVE RAT (Dahl-55) MODEL 
OF HYPERTENSION 
Dahi-SS were developed by Lewis Dahl through the selective inbreeding 
of Sprague-Dawley rats (Dahl et a/., 1962). Two substrains of rats were 
generated, a salt sensitive strain (Dahi-SS) that developed hypertension in 
response to a high salt-diet (8% NaCI) and a salt resistant strain (Dahi-SR) that 
remained normotensive when fed high salt. Blood pressure rapidly rises in the 
Dahi-SS fed high salt (8% NaCI from weaning) and hypertension (systolic BP of 
170mmHg) was observed within 2 weeks (Simchon eta/., 1991). After 4 weeks 
Dahi-SS fed 8% NaCI initially develop hypertension due to an expanded blood 
volume, which increased cardiac output with no change in peripheral resistance 
(Simchon et a/., 1989). However, by 8 weeks cardiac output normalized and 
peripheral resistance increased (Simchon et a/., 1991 ). The renal vasculature of 
high salt fed Dahi-SS also exhibited impaired vasodilation in response to atrial 
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natriuretic peptide and sodium nitroprusside (Simchon et a/., 1996). It was 
suggested that hypertension development in Dahi-SS (fed high salt) initially 
involved an elevation in cardiac output secondary to an increase in blood volume 
associated with an increase in renal vascular resistance to blood flow (perhaps 
as a result of an inability of the renal vasculature to vasodilate). This was 
followed by an increase in total peripheral resistance to flow leading to the 
maintenance of hypertension. (Simchon eta/., 1989; Simchon eta/., 1991 ). 
1.5.1 The Role of Altered Renal Function in the Development of 
Hyperte1nsion in Dahl-55 
The kidney plays a key role in hypertension development within Dahi-SS. 
Renal transplant studies have demonstrated that transplanting kidneys from 
Dahi-SS into Dahi-SR allows the latter rats to develop hypertension when they 
are fed high salt whereas a reverse renal transplant attenuates hypertension 
development in Dahi-SS (Dahl & Heine, 1975). 
1.5.2 Renal Pathology Associated with Hypertension Development in Dahl-55 
Hypertension development in Dahi-SS is associated with profound 
morphological alterations in the kidney. Characteristically, the kidneys of Dahi-SS 
exhibit a progressive thickening of the intrarenal vessels and arteriolar fibrinoid 
necrosis (Karlsen et a/., 1997). Although some glomeruli appear normal, focal 
changes in glomerular morphology (crescent shape) produced by glomerular 
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sclerosis and necrosis and widespread renal degeneration were observed. There 
was marked tubular atrophy and interstitial inflammation (Karlsen et a/., 1997) as 
well as a thickening of the glomerular basement membrane, and a broadening of 
the podocyte pedicles (Sterzel eta/., 1988). Dahi-SS fed high salt also exhibited 
an accumulation of fibrinoid material in the intima of renal arteries, proteinaceous 
tubular casts and atrophy of the cortical tubules and glomeruli (Rapp & Dene, 
1985). The above alterations were first observed in Dahi-SS 2 weeks after high 
salt feeding (Rapp & Dene, 1985). 
1.5.3 Status of the Renin Angiotensin System in Dahl-55 
Dahi-SS fed 8% NaCI for 4 weeks exhibited suppressed plasma renin levels. 
Subsequently, renin levels increased to above baseline levels after 8 weeks of high 
salt feeding (von Lutterotti eta/., 1992). The rise in renin activity was correlated with 
the appearance of renovascular lesions. Renin secretion increased as renal 
function decreased. 
Other studies have shown that the infusion of ANG II (10 or 50 ng/kg/min) 
into Dahi-SS fed high salt (4% NaCI) promotes proteinuria, glomerular lesions 
and a reduction in the glomerular filtration rate (Hirawa et a/., 1995). These 
.. effects were attenuated by ANG II receptor blockade (Hirawa eta/., 1995). It was 
suggested that the renal vasculature of Dahi-SS was more sensitive to ANG II 
than that of Dahi-SR and this difference in sensitivity predisposed the renal 
vasculature to develop lesions in response to a high salt diet (Hirawa et a/., 
16 
1997). Losartan (an AT1 receptor antagonist), has been shown to reduce the 
incidence of stroke development in Dahi-SS fed high salt (von Lutterotti et a/., 
1992). 
1.6 STROKE DEVELOMENT in DAHL-55 RATS 
Studies have described "stroke" associated mortality in Dahi-SS fed high 
salt (Tobian eta/., 1984; Tobian eta/., 1985; Werber eta/., 1985; von Lutterotti et 
a/., 1992; Lin eta/., 1999; Zhang eta/., 1999). 
Tobian et a/ (1985) studied Dahi-SS fed a Japanese-style diet 
supplemented with 4% NaCI between the ages of 3 to 5 weeks and 8% NaCI 
thereaftter. After 9 weeks of salt feeding Dahi-SS exhibited a 55% mortality 
associated with presence of cerebral hemorrhage or infarcts. 
Vl/erber et al. (1985) observed the presence of both hemorrhagic and 
ischemic lesions in Dahi-SS fed a high salt Japanese or American (Purina) style 
diet. Hemorrhagic lesions were described as consisting of blood filled 
intracerebral spaces. Ischemic lesions were classified on the basis on neuronal 
degeneration, the presence of neutrophils, macrophages, and tissue loss is the 
.absence~ of hemorrhage (Werber eta/., 1985). Kidney damage (nephrosclerosis), 
lung ed1ema and cardiac hypertrophy were also present (Werber et a/., 1985). 
The incidence of stroke development was higher in Dahi-SS fed a Japanese 
(83%) versus an American (57%) style diet despite the fact that the latter diet 
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contained a slightly higher Na+ content (1.23 vs 1.18 mEq/g) (Werber et a/., 
1985). 
Von Lutterotti et a/ (1992) found that when Dahi-SS were fed 8% NaCI 
from 5 to 6 weeks of age they developed behavioural abnormalities consistent 
with 'stroke development. Ischemic and hemorrhagic cerebrovascular lesions 
were dE~tected 6 weeks after the initiation of a high salt diet and an 82% 
incidence of lesions was observed in rats fed high salt for 10 weeks. 
Hemorrhages occurred in 21% of the brains and ischemic infarcts occurred in all 
brains (von Lutterotti et a/., 1992). Animals often exhibited multiple cerebral 
lesions. Ninety four % of the rats had lesions in the occipital cortex, 68% had 
lesions in the corpus callosum, 18% in the hippocampus and 25% developed 
lesions in the brainstem (von Lutterotti eta/., 1992). 
Other studies observed that Dahi-SS fed 4% NaCI from 4 weeks of age 
develop behavioral abnormalities consistent with stroke (such as, convulsive 
repetitive forearm movements, marked lethargy and semiplegia) after 5.5 weeks 
of high salt feeding (Lin eta/., 1999; Zhang eta/., 1999). There was no fixed time 
frame of death after the onset of stroke (Lin eta/., 1999; Zhang eta/., 1999). Both 
hemorrhagic (confirmed by the gross evaluation of thick coronal sections) and 
~ischemic (confirmed by the histological use of 2,3,5 triphenyltetrazolium chloride) 
stroke was verified in these rats (Lin eta/., 1999; Zhang eta/., 1999). 
The age at which a high salt diet is initiated strongly influences the onset 
of mortality in Dahi-SS (Pfeffer et a/., 1984). In this regard, it is not unusual to 
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observe no mortality in animals until after 16 weeks of age when the rats are fed 
an 8% NaCI diet from six weeks (Qu et a/., 2000) and a 55% mortality associated 
with stroke by 12 weeks of age when the rats are fed high salt from 3 to 5 weeks 
of age (Tobian eta/., 1985). 
1.7 A SUMMARY OF THE RATIONALE AND THE INITIAL OBJECTIVES OF 
THE CURRENT STUDY 
The focus of research within our laboratory is to gain an understanding of 
the mechanisms involved in producing stroke during hypertension and to develop 
treatment interventions that can either delay the onset of stroke or prevent death 
and disability after stroke has developed. The limited availability of animal 
models that develop stroke without chemical or surgical intervention has been a 
key challlenge in achieving the above goals. 
As noted in the preceding review of the literature, very few animal models 
develop stroke in a spontaneous manner during hypertension. Stroke 
development has been noted in Goldblatt (one and two kidney) forms of renal 
hypertension in rats (Byrom, 1 969). However, in these models the occurrence of 
stroke is not predictable. It does not occur in all renal hypertensive rats and when 
it does occur, the onset of stroke does not follow a consistent chronological 
pattern after hypertension development (Byrom, 1 969). It is therefore difficult to 
assess the physiological alterations preceding and potentially promoting stroke 
development using Goldblatt renal hypertensive rats. 
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SHRsp were the first animal model of hypertension that developed stroke 
in a predictable manner (Yamori eta/., 1984). When SHRsp were fed a Japanese 
style die~t containing 4% NaCI, hemorrhagic stroke developed at about 12 weeks 
of age and a 1 00% mortality associated with stroke occurred by 16 weeks of age 
(Smeda, 1989). Studies of these animals produced unique insights as to the 
mechanisms that might be involved in promoting hemorrhagic stroke. Initially, 
researchers believed that hemorrhagic stroke development in SHRsp was a 
simple consequence resulting from the presence of a very high blood pressure. 
This view was challenged by studies that indicated that the treatment of SHRsp 
with : ACEis at doses that did not alter blood pressure delayed stroke 
development in SHRsp to an extent where the rats survived to a near normal life 
span (Stier et a/., 1989; Stier et a/., 1991; Macleod et a/., 1997). It was 
·demonstrated that ACEis such as captopril suppressed the elevated plasma 
aldosterone levels observed in these animals and that the beneficial effects of 
captoprill could be negated if during treatment, aldosterone levels were allowed to 
increase. These studies indicated that hemorrhagic stroke development in 
SHRsp Gould be retarded and re-established by modifying the aldosterone arm of 
the renin-angiotensin-aldosterone system under conditions where the level of 
hypertension remained unaltered in SHRsp (Stier eta/., 1989; Stier et a/., 1991; 
Macleod et a/., 1997). Other studies observed that CBF autoregulation became 
defective in SHRsp prior to stroke development and that this alteration was 
associated with defects in the ability of cerebral arteries to constrict in response 
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to pressure (a mechanism thought to promote CBF autoregulation) (Smeda, 
1992). It was hypothesized that hemorrhagic stroke may be produced in SHRsp 
by a bn3akdown in the ability of cerebral blood vessels to regulate CBF under 
hypertensive conditions (Smeda et a/., 1999b). Under the latter conditions an 
elevation in blood pressure could lead to cerebral overperfusion which might 
promote vessel rupture and cerebral hemorrhage. It was further suggested that 
the development of renal dysfunction in SHRsp during hypertension (producing a 
reduction in glomerular filtration) could potentiate stroke development by causing 
the activation of the renin-angiotensin-aldosterone system and by the induction of 
bleedin~l tendencies secondary to uremia (Smeda, 1992, 1997). The observation 
that hemorrhagic stroke and defects in cerebrovascular pressure dependent 
constriction could be induced to occur in stroke resistant SHR by renal 
-manipulations that produced uremia (Smeda, 1992) and the further observation 
that ACEI treatment promoted a protective effect against renal dysfunction led to 
the speculation that alterations in renal function may be responsible for the loss 
of CBF autoregulation in SHRsp (Macleod eta/., 1997). 
A key question raised in relation to the studies involving SHRsp was 
whether the mechanisms hypothesized to be involved in promoting hemorrhagic 
stroke development in SHRsp were widely applicable to hemorrhagic stroke 
development in humans and other animal models. In this regard, an argument 
could be presented that SHRsp represent a highly inbred, genetically distinct 
model of hypertension and that the hormonal and cerebrovascular changes 
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associated with hemorrhagic stroke are unique to this model and not applicable 
to hemorrhagic stroke in other animals or in humans. Therefore the initial 
incentive in carrying out the current study was to assess the mechanisms 
involved! in promoting spontaneous hemorrhagic stroke in another animal with the 
general objective to assess whether some of these mechanisms were common 
to those observed in SHRsp. 
Aside from SHRsp only Dahi-SS have been noted to develop a high 
incidence of spontaneous stroke during hypertension (Tobian eta/., 1984; Tobian 
eta/., 1985; Werber et a/., 1985; von Lutterotti eta/., 1992; Lin et a/., 1999; 
Zhang e~t a/., 1999). 
The majority of studies involving Dahi-SS have assessed the mechanisms 
involved in promoting hypertension development in this model. The latter studies 
provide little insight on the specific mechanisms leading to stroke development. 
The incidence and onset of stroke development reported in Dahi-SS also varies 
.. 
between studies (Tobian eta/., 1984; Tobian eta/., 1985; Werber eta/., 1985; 
von Lutterotti eta/., 1992; Lin eta/., 1999; Zhang eta/., 1999). 
In our view, such variations could be due to the type of diet being fed to 
the rats (a Japanese style diet versus Purina rat chow), the level of salt in the diet 
(i.e. 4% versus 8% NaCI) and the time after weaning when a high salt diet is fed 
' to the rats (i.e. 3, 4, 5 or 6+ weeks of age). In addition, the type of stroke that 
develops (ischemic versus hemorrhagic) and the brain areas where stroke 
develops are poorly defined. Studies have reported evidence of stroke based on 
, 
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the presence of neurological dysfunction thought to be consistent with stroke (i.e. 
seizures and convulsions) without a demonstration of the presence and types of 
cerebrovascular lesions present (Zhang et a!., 1999). In other studies the 
presence of cerebral infarcts and hemorrhages has been noted without a clear 
description of the location of these lesions (Lin et a/., 1999; Zhang et a/., 1999). 
Based on the current literature it is unclear as to whether Dahi-SS develop 
ischemic brain lesions in the absence of cerebral hemorrhage. Although cerebral 
hemorrhage is the predominant lesion observed in Dahi-SS with stroke, cerebral 
infarcts lacking the presence of hemorrhage have been noted (Tobian et a/., 
1984; Tobian et a/., 1985). Such observations have lead to the speculation that 
occlusive forms of cerebrovascular disease that produce ischemia might also be 
present in Dahi-SS. 
A. clear description of the type of stroke development (ischemic versus 
hemorrhagic) in the brain is important in assessing the mechanisms of stroke 
development in Dahi-SS. Distinctly different mechanisms are involved in 
promoting brain ischemia (occlusive arterial disease/thromboembolism) versus 
cerebral hemorrhage (over perfusion and vascular rupture). Hence the design of 
the subsequent experiments would be dictated by the type of stroke development 
and the cerebral location of stroke would focus the area of study to specific 
cerebrovascular arterial beds. 
Initial objectives of the experiments in the current study were to determine 
if Dahi-SS fed a high salt diet developed stroke spontaneously in a predictable 
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manner when fed high salt and to characterize the type of stroke development 
and the location of cerebrovascular lesions. In an attempt to attain the highest 
degree of consistency and predictability in stroke development we bred our own 
Dahi-SS rats and used only male animals in the study. In addition we created our 
own . die~t by reconstituting a readily available Purina rat chow formula with 
accuratE~ concentrations of NaCI. By breeding our own Dahi-SS we could assure 
genetic uniformity in our rats as well as accurate aging and high salt delivery at 
exactly 5 weeks of age. We believed that by using this experimental design we 
could overcome the variations in the incidence and perhaps even the nature of 
stroke observed in previous studies involving Dahi-SS rats. The working 
hypothesis at the initiation of the study was that when Dahl- SS rats were fed an 
appropri1ate level of salt they would develop hemorrhagic stroke in a predictable 
. man~er. We further believed that hemorrhagic stroke would occur at a time when 
renal damage secondary to hypertension would create a high renin-high 
aldosterone milieu in the rats and that onset stroke development in the rats would 
be retarded by ACEI treatment in a manner not dependent on the suppression of 
blood pressure. At the initiation of the study we felt that the probability of ACEI 
treatment achieving the latter goals was high due to previous observations that 
indicated that hemorrhagic stroke development was retarded in Dahi-SS by 
losar:tan (AT -1 receptor antagonist) treatment (von Lutterotti eta/., 1992). 
Subsequent experiments were planned to assess the alterations in CBF 
autoregulation in the regions where stroke developed and to further assess 
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cerebrovascular pressure dependent constriction in the vascular beds perfusing 
these regions. Studies were designed to test the hypothesis that a loss of CBF 
autoregulation and cerebrovascular pressure dependent constriction preceded 
blood brain barrier disruptions in cerebral regions involved in stroke 
development. 
The activation of protein kinase C has been shown to be involved in the 
signal transduction mechanisms promoting cerebrovascular PDC (Osol et a/., 
1991; Karibe et a/., 1997; Kirton & Loutzenhiser, 1998; Smeda et a/., 1999a). If 
defects in cerebrovascular pressure dependent constriction were observed in 
Dahi-SS, further experiments were planned to assess the hypothesis that a loss 
in cerebrovascular PDC was associated with defects in the ability of PKC to elicit 
cerebrovascular constriction. 
Many studies involving Dahi-SS have shown that both the basal and 
antgonist induced vasodilation mediated by nitric oxide released from the 
endothelium is altered in vascular beds (Chen & Sanders, 1993). Currently there 
are no studies assessing this function in the cerebrovasculature of Dahi-SS. 
Studies have shown that the basal release of nitric oxide from the endothelium 
and non endothelial sources of nitric oxide synthase modulates cerebrovascular 
PDC. Specifically, the basal release of NO within cerebral vessels governs basal 
:tone and modifies the operating range of cerebrovascular PDC. Endothelial 
removal or the inhibition of NO synthase causes PDC to occur at more 
constricted lumen diameters (Smeda, 1993). In view of this, studies were 
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undertalken to assess endothelial and NO vasodilatory function in the 
cerebrovasculature of Dahi-SS. The initial aim of these studies was to test the 
hypothesis that altered NO function in relation to stroke development in Dahi-SS 
potentially altered basal tone and cerebrovascular PDC in a manner that might 
be expected to modify CBF autoregulation. 
The results and conclusions of the above studies have been organized in 
sequential chapters titled "The characterization of stroke development in Dahi-
SS", "Alterations in cerebrovascular autoregulation and myogenic function in 
Dahi-SS", "Cerebrovascular alterations in pressure and protein kinase C 
mediated constriction in Dahi-SS" and "Alterations in cerebrovascular endothelial 
function in Dahi-SS. 
CHAPTER 2 
THE CHACTERIZATION OF "STROKE" DEVELOPMENT IN DAHL-55 
2.1 INTRODUCTION 
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There is a strong correlation between hypertension and stroke 
development in humans (Collins et a/., 1990; MacMahon, 1990; Strandgaard, 
1996). No studies have evaluated the cerebrovascular alterations in Dahi-SS 
that precede the onset of stroke development. Previous studies involving SHRsp 
have demonstrated the first observations of behavioural signs of stroke at 12 
weeks of age (Smeda, 1989, 1992). The type of stroke in this model was 
hemorrhagic in origin. Although the mechanisms underlying stroke development 
in SHRsp remain unclear, alterations in renal function and the RAS likely play a 
role in initiating cerebral hemorrhage. Extensive research has demonstrated that 
followin~J the administration of a high salt diet, both ACEis and the ANG II 
receptor antagonist losartan, delay or prevent the onset of stroke development in 
SHRsp (Stier eta/., 1989; Camargo eta/., 1991; Kim eta/., 1992; Camargo eta/., 
1993; Le~e & Severson, 1994; Macleod eta/., 1997). This occurs in the absence 
of an antihypertensive effect during treatments (Stier eta/., 1989; Camargo eta!., 
1991; Camargo eta/., 1993; Lee eta/., 1994; Macleod eta/., 1997). Plasma 
.. renin activity is elevated in SHRsp fed high salt (Volpe et a/., 1990; Camargo et 
a/., 199'1; Gahnem eta/., 1994; Macleod eta/., 1997). This is unique since a 
high salt: diet typically lowers plasma renin activity in SHR (Shibata eta/., 1979). 
The mechanisms underlying the anti-stroke effect produced by ACEis or losartan 
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remain unclear but experiments by Macleod et a/. (1997) have suggested a 
potential role for aldosterone in the cascade of events leading to stroke. 
Elevations in plasma renin activity promote an increase in plasma ANG II levels, 
which stimulates the release of aldosterone from the adrenal gland (Gupta et a/., 
1995). Plasma aldosterone levels are elevated in SHRsp after the establishment 
of hypertension and are further increased in poststroke versus prestroke SHRsp 
(Kim eta/., 1992; Macleod eta/., 1997). ACEI inhibitor treatment with captopril 
suppresses plasma aldosterone levels and re-elevation of plasma aldosterone 
(via osmotic pumps) during treatment negates the antistroke effects produced by 
captopril (Macleod eta/., 1997). 
Some studies have shown that Dahi-SS also exhibit a delay in the onset of 
stroke and protection against the vascular degeneration when they are treated 
with losartan (von lutterotti et a/., 1992). The beneficial effect of losartan also 
occu_rs under conditions where only a modest reduction in blood pressure is 
observed (von lutterotti eta/., 1992). 
2.2 OBJECTIVES AND HYPOTHESES OF THE STUDY 
The focus of these experiments was to characterize stroke development in 
Dahi-SS, comparing its etiology to stroke development in SHRsp. Our hypothesis 
was that Dahi-SS rats will develop hemorrhagic stroke following the initiation of a 
high salt diet and that stroke development will be prevented by ACEI treatment 
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with captopril, through a mechanism involving the reduction of plasma 
aldosterone. 
2.3 METHODS AND MATERIALS 
2.3.1 Animals 
The Dahl Salt-Sensitive (Dahi-SS) and Salt-Resistant (Dahi-SR) animals 
were obtained from a maintained colony housed within the Animal Care Facilities 
(Memonial University of Newfoundland, Health Sciences Center, St. John's). The 
experiments were performed in accordance with guidelines outlined by the 
Canadian Council on Animal Care and the Memorial University of Newfoundland 
Animal Care Committee. Animals were housed in rooms on a 12-hour light/dark 
cycle. All experiments were conducted on male animals only. The colony was 
maintained by breeding brother-sister siblings at 8 weeks of age. The litters were 
weaned at 5 weeks and the separated males were placed on the appropriate diet 
(see Die~t section for more detail). 
2.3.2. Di1et 
Dahi-SS and Dahi-SR rats were separated into groups and fed diets 
containing differing percentages of NaCI. The diet was made from a standard rat 
chow (Prolab RMH 3000 formula, PMI Feeds Inc., St Louis MO, USA) containing 
a basallievel of 0.7% NaCI. This diet was then supplemented with NaCI. The diet 
was ground to a coarse grain using an electric grinder (Dayton gear motor, 
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Dayton Electric Co., Chicago, IL, USA). NaCI (Sigma-Aldrich Canada Ltd. 
Oakville, Ontario, Canada) was added supplementing the NaCI levels to 6. 7% or 
8.7% (by weight). The required level of NaCI was dissolved in a volume of water 
equalin~} 70% of the weight of the powder (that was to be reconstituted). The 
water containing the NaCI was mixed with the powdered chow to form a thick 
paste that was dried with fans at 23°C for 12 hours. The dried diet was broken 
into small biscuits and fed to the rats. Fresh diet was made every few days. 
2.3.3 Protocols 
Dahl rats were separated into 6 groups at 5 weeks of age. These 
included: Dahi-SS fed normal salt (0.7% NaCI), Dahi-SS fed 8.7% NaCI, Dahi-SS 
fed moderate salt (6.7% NaCI) as well as Dahi-SS fed 8.7% NaCI that were 
treated with captopril (50 mg/kg/day). Control groups consisted of Dahi-SR fed 
normal salt (0.7% NaCI) and Dahi-SR fed 8.7% NaCI were also included in the 
study. Captopril was administered via the drinking water (the concentration was 
achieved by modifying drug dosage and drinking rates of animals in order to 
achieve a 50mg/Kg/day dosage). Each experimental group consisted of 5 
animals. 
2.3.4 Blood Pressure Measurement 
The systolic blood pressure was measured weekly via a tail cuff 
compression method (IITC Model 29, Pulse Pressure Amplifier, Woodlands Hills, 
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CA). The rats were placed in a room at a controlled temperature of 35°C for 15 
minutes prior to BP measurement. The averages from three recordings were 
taken once the animal had become acclimated to the environment. Blood 
pressurHs were measured on a weekly basis. 
2.3.5 Mc>nitoring of Stroke Development 
The rats were monitored daily for any signs of stroke development. 
Previous studies with SHRsp have characterized the symptoms associated with 
stroke development (Smeda, 1989, 1992). These symptoms include convulsive 
repetitiv1e forearm movements, which are followed by an altered posture in which 
the rat iis hunched over with its legs hyper-extended (kangaroo-type posture). 
The animals exhibit poor grooming and lethargy. Dahi-SS rats were monitored 
closely for the development of any of these symptoms and others that are not 
congruent with normal behavior. When rats exhibited signs of stroke 
development, or when death was likely to occur, the rats were anesthetized and 
a blood sample was taken via cardiac puncture. Subsequently, the brains and 
kidneys were removed and fixed in 10% formalin for histological examination. All 
brain~ were examined closely prior to fixing in order to observe any surface 
morphological abnormalities consistent with hemorrhagic stroke or other 
patholog1ical changes. 
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2.3.6 A!;sessment of Brain Ischemia, Hemmorhage and Blood Brain Barrier 
Integrity 
Ischemic brain damage was assessed in the following groups: Dahi-SS 
fed normal (0.7% NaCI) salt, asymptomatic Dahi-SS fed high salt (8.7% NaCI), 
Dahi-SS fed high salt (post-stroke) and Dahi-SR fed high salt. A 2,3,5 
triphenoltetrazolium chloride assay (TTC, Sigma-Aldrich, Oakville, Ontario, 
Canada) was used to assess the presence of brain ischemia. Six animals were 
examined from each group. (Lundy et a/., 1986) describes the method used. 
Brains (including brain stem) were removed and placed in oxygenated ice-cooled 
(4°C) Krebs physiological salt solution (95% 02, 5% C02, pH 7.4). Unfixed 
brains were then sliced using a jig (FBM-1000c, ASI instruments, USA). Serial, 
coronal sections of brain were immersed in normal (0.9%) saline containing 4% 
TTC for 30 minutes at 37°C. Tetrazolium was taken up by the brain and 
dehydrogenases converted this compound to an impermeable red dye that 
'remained within the cells. Ischemic damage inactivated cellular dehydrogenase 
·leading a failure of TTC to be converted to a red dye. Areas of the brain that had 
been subjected to ischemic damage failed to react and remained unstained. 
The brains of 7 rats from each of the above groups were fixed in buffered 
10% formalin, imbedded in paraffin and sectioned (15 IJm thick slices). The 
sections were subsequently stained either with cressyl violet blue or hematoxylin 
and eosin. Other sections were stained for the presence of glial fibrillary acidic 
protein (GFAP) which accumulates in astrocytes after Ischemic damage (Burtrum 
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& Silverstein, 1994). The slides were examined for changes consistent with the 
occurrence of brain ischemia and hemorrhage. The brains of 26 additional Dahi-
SS rats exhibiting signs of stroke were fixed in 10% buffered formalin and 
sectioned in 1 mm thick coronal sections in an anterior to rostral direction from 
the olfactory bulbs to the brainstem just behind the cerebellum using a jig (ASI 
instrumEmts). These sections were studied through a back-light dissecting 
microscope for the presence of intracerebral hemorrhage. This technique has 
been previously used to study brains of SHRsp that have developed stroke 
(Smeda, 1989) and is capable of detecting even the smallest intracerebral 
hemorrhages. 
The integrity of the blood brain barrier was evaluated in 6 Dahi-SS 
exhibiting behavioural signs of stroke. Rats were anaesthetized with sodium 
pentobarbital (65mg/Kg, ip) and placed on a heating pad. The right femoral vein 
was catheterized with PE-10 tubing and Evan's blue dye (30 mg into 1 ml of 
sterile 0.9% saline) was infused (over a 15 second period) into the animal at a 
level of 30 mg Evan's blue dye per kg body weight. The dye was allowed to 
circulate for 12 minutes. After 12 minutes, the abdominal cavity was opened and 
two hemostats (5 em tips) were inserted through the diaphragm in a manner 
where the intercostal arteries and veins located in the thoracic cavity to the right 
and left of the sternum were clamped. The chest cavity was opened to expose 
lhe hea1i and a PE-50 catheter was inserted into the aorta and tied at the base of 
the heart. The right and left ventricles were cut allowing free outflow. Clean 
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0.9% saline was perfused in to the aorta at constant pressure of 200 mmHg for 
one minute. This latter infusion cleared the Evan's blue containing intravascular 
blood from the cerebral vasculature leaving only the dye that leaked into the 
extravascular space. The skull was subsequently opened and the brain (from the 
olfactory bulbs to the point at the start of the spinal cord where the vertebral 
arteries join to from the basilar artery) was removed and frozen in liquid nitrogen. 
To prevent the brain from cracking, the brain was placed on a plastic lid that was 
floated on the liquid nitrogen. The brains were then stored at -80°C for 
subsequent analysis. 
VI/hen this procedure was used, sites of Evan's blue were clearly visible 
against the opaque matrix of the brain (Evan's blue works by conjugating to 
plasma albumin). The extravasation of Evan's blue indicated the existence of 
breaks in the BBB of a size sufficiently large enough to permit the movement of 
albumin plus conjugated dye (Udaka eta/., 1970). 
Measurements of the brain wet to dry weight ratio were used to assess 
brain eclema. Animals (n=15) were anesthetized and the brains were removed 
and weighed to determine the wet weight. Brains were then placed in pre-
weighed vials and dried in an oven at 70°C for 24 hours. Subsequently, the dry 
weight of the brain was determined. Brain water content was determined using 
the following formula ((wet weight minus dry weight/wet weight) X 1 00)). 
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2.3.7 REmal Function Analysis 
Dahi-SS fed normal salt (0.7% NaCI) and Dahi-SS and Dahi-SR fed high 
salt (8.7'% NaCI) diets were housed individually in metabolic cages for 24 hours 
to collect urine samples. Five animals from each group were examined. Food 
and water was provided. Kidney function was evaluated on the basis of 
creatinine clearance and total protein excretion in the urine over a 24-hour period 
calculated from the collected urine samples. Following 24 hours the animals 
were weighed, total urine volume was determined and blood pressure was 
measured. The rats were anesthetized and a blood sample was taken via 
cardiac puncture. The sample of blood (3 ml) was centrifuged (14000 
revolutions/sec) and the plasma was retained for analysis. The urine was then 
analyzed for total protein and creatinine levels and the plasma was assessed for 
creatinine, albumin and urea content by the hospital (Biochemistry/Hematology 
Laboratory, Memorial University, Health Science Center Hospital, St. John's, 
Newfoundland, Canada). Qualified individuals who conduct these tests on a 
routine basis performed the analyses. The personnel were blind as to the 
identity of the samples. Creatinine clearance (CC) was determined using the 
followin~J formula: CC (mllhr) = [(urine creatinine, 1JM)(24-hr urine volume, ml) 
serum creatinine, !JM)]/24. The urinary protein excretion (PE) rate was 
calculated using the following formula: PE (mg/hr) = (urinary protein, mg/L)(24-hr 
urine volume, L)/24. The urinary excretion of protein was expressed in relation to 
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creatinine clearance (PE/CC x1 03/Kg), which estimates the amount of protein lost 
in relation to glomerular filtration. 
Due to the rapid expiration of the Dahi-SS (fed 8.7% NaCI) after the 
observation of behavioural symptoms suggesting stroke (1 day, discussed later), 
post-stroke Dahi-SS could not be evaluated. Therefore, Dahi-SS fed a high salt 
diet for :2 weeks (and exhibiting no behavioural signs of stroke), Dahi-SR fed the 
same diet for 5 weeks and Dahi-SS fed a normal salt were compared and 
assesse~d for proteinuria. 
2.3.8 lmmunoassays for Aldosterone 
Dahi-SS (n=24) and Dahi-SR (n=15) were anesthetized and blood 
samples were taken via cardiac puncture. The sample of blood (3 ml) was 
centrifu~~ed (14000 revolutions/sec) and the plasma was frozen (-80 °C) for a 
later analysis of aldosterone. Serum aldosterone was measured by 
radioimmunoassay techniques by the Memorial University, Health Science 
Center Renal Diagnostic Laboratory (St John's, Newfoundland, Canada). The 
assays were performed using a Coat-A-Count radioimmunoassay kit (Diagnostic 
Products Corp). 
2.3.9 Statistical Analysis 
Comparisons involving 2 groups of data were assessed with student's t 
test. A one-way analysis of variance (ANOVA) followed by Fisher's post hoc test 
was used to assess comparisons involving one parameter in multiple groups. 
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Data expressed in the forms of curves, which represented groups of animals, 
were assessed using a general linear model (GLM) of multivariant analysis of 
variance (MANOVA). The curves representing rat groups were assessed to 
determine if they significantly differed from each other and were further assessed 
to determine if a differential interactive effect existed between the response (y-
axis, i.e. BP, CBF, vascular constriction) and a given variable (x-axis, i.e. time, 
dose, a~~e). A significant interactive effect is usually associated with a situation in 
which curve crossover occurs. Results were considered significant at P<0.05 and 
were expressed as the mean±SEM. In all cases N values represent the number 
of rats used in each experiment. 
2.4 RESULTS 
2.4.1 Blood Pressure, "Stroke" Development and Mortality 
Dahi-SS and Dahi-SR were fed diets containing varying levels of NaCI 
from' 5 weeks of age. The blood pressure profile for each group is outlined in 
Figure ·1. All Dahi-SS groups fed a high salt (8. 7% NaCI) or a moderate salt 
.(6. 7% NaCI) diet developed a rapid onset of hypertension (systolic BP >150 
mmHg) one week after being fed high salt. Conversely, Dahi-SR fed a normal 
(0.7% NlaCI) or high salt (8.7% NaCI) did not develop hypertension. Dahi-SS fed 
normal salt (0.7% NaCI) developed moderate levels of hypertension (about 170 
mmHg) over the first 5 weeks of feeding. Captopril (50 mg/kg/day) treatment did 
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Figure '1: Alterations in systolic blood pressure in relation to feeding duration in 
Dahl salt-sensitive (Dahi-SS) and Dahl salt-resistant (Dahi-SR) rats fed varying 
levels of NaCI. Dahi-SS fed a 8. 7% NaCI diet and treated with captopril (50 
mg/kg/day) exhibited no significant reduction in blood pressure when compared 
to Dahi-·SS fed either 8.7% or an 6.7% NaCI diet without captopril treatment. 
Blood pressure recording was terminated at six weeks in Dahi-SS following 
initiation of an 6.7% or 8.7% NaCI diet due to the fact that the rats were either too 
sick to have their blood pressure recorded or had died prior to six weeks of 
feeding. All Dahi-SS rats on high salt diets exhibited behavioral symptoms of 
stroke while Dahi-SR fed the same diet remained asymptomatic. Dahi-SS fed 
0.7% NaCI and Dahi-SR fed 0.7% or 8.7% NaCI continued to live up to 17 weeks 
of age (12 weeks of salt feeding) to the termination of the experiment. These 
groups exhibited no signs of stroke. Statistics: General Linear Model MANOVA-
All high salt groups (except F) were significantly different from normal salt groups 
(Band E). All Dahi-SS groups (A,B,C,D) were significantly different from Dahi-SR 
groups (E and F), P<0.05. Values equal the mean± SEM (5 animals per group). 
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not effect the onset of hypertension or the maximum level of hypertension 
(systolic BP >200 mmHg) attained in Dahi-SS fed 8.7% NaCI (Figure 1). 
All Dahi-SS fed 8.7%, 6.7% NaCI or an 8.7% NaCI diet combined with 
captopril treatment exhibited behavioural abnormalities consistent with the 
development of stroke. This included repetitive head movements, flexion of the 
forelimbs, which was usually confined to the right side. Postural abnormalities 
previously defined as a "kangaroo stance" (whereby the animal was seated 
upright with hindlimbs underneath the body) were observed. The animals often 
entered a phase of marked lethargy and immobility, confirmed by patches of 
urine soaked bedding. All the animals died or were sacrificed (when it was 
evident that death was imminent) within 24-48hrs after the symptoms were 
detected. The animals were carefully examined prior to death. Common 
terminal! features observed included immobility, dramatic weight loss and cool 
body temperature possibly due to poor circulation. There was often a sustained 
erection, possibly indicative of brain pathology that may have led to abnormalities 
in the autonomic nervous system. Post-mortem analysis revealed marked 
accumulation of fluid in the extravascular space of the abdominal cavity 
(ascities). Figure 2 outlines the mortality profiles of the rats in relation to duration 
of high salt feeding (initiated a 5 weeks of age). Fifty-percent mortality occurred 
in the Dahi-SS fed 8.7% or 6.7% NaCI after 3 to 4 weeks feeding. Dahi-SR fed 
the 8. 7cvo salt diet did not develop stroke associated behavioural symptoms and 
exhibited a 100% survival rate for the duration of the experiment (12 weeks of 
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Figure :2: Mortality profile of Dahi-SS and Dahi-SR fed a diet containing various 
concentrations of NaCI (+/- captopril treatment). All Dahi-SS fed high salt diets 
(8. 7%, E>. 7% and 8. 7% NaCI+captopril) exhibited comparable mortality profiles in 
relation to duration to feeding. Death was preceded by the presence of stroke-
like behavioural symptoms. A 50% level of mortality was reached around 4.5 
weeks. No significant difference in mortality with respect to feeding duration was 
observed between Dahi-SS fed 6.7%, 8.7% NaCI or NaCI with captopril 
treatment. No mortality was observed in the Dahi-SR groups fed 0.7% and 8.7% 
NaCI and in Dahi-SS fed 0.7% NaCI. These latter groups represented by the star 
like overlay extending from 100% survival over the duration of the experiment. 
(n=5 animals per group). Statistics: General Linear Model MANOVA- Groups A, 
B, and F were significantly different from C, D and E, P<0.05. Symbol across 
from 1 00% on the y-axis represents groups C, D and E. 
salt feeding). Captopril had no effect on the onset of mortality in Dahi-SS fed 
8.7% NaCI. 
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2.4.2 An Assessment of Cerebrovascular Lesions in Dahl-55 Exhibiting 
Behavic>ural Symptoms of Stroke 
Brains were removed from asymptomatic Dahi-SS, Dahi-SS with 
behavioural symptoms of stroke and Dahi-SR fed 8.7% NaCI for 2, 3.5 and 5 
weeks respectively. The brains were serially sectioned in 1 mm thick coronal 
sections from the olfactory bulb area to the brain stem at a point where vertebral 
arteries join to form the basilar artery. The sections were examined using TTC 
assay outlined in the methods. Bright brick red staining occurred within all brains 
across all sections (n=6 rats/group). The red reaction indicated the robust 
cellular dehydrogenase conversion of TTC to a red dye, a feature that is 
inconsistent with the presence of cerebral ischemia. 
The brains of 7 Dahi-SS fed 8.7% NaCI were histologically examined. 
These brains were fixed in formalin and imbedded in paraffin. Each brain was 
coronally serially sectioned in 151Jm thick sections. The sections were stained 
with one of the following stains: Cressyl violet, hematoxylin and eosin or for the 
presence of glial fibrillary acidic protein (which accumulates in the astrocytes 
after ischemic damage). These histological analyses failed to detect any 
evidence of ischemic damage. 
Other brains (n=26 rats) from Dahi-SS exhibiting behavioural symptoms of 
stroke were sectioned in 1 mm thick coronal sections and studied under a 
dissecting microscope for the presence of intracerebral hemorrhage. All the 
analyses indicated the presence of intracerebral hemorrhage in 7 out of 39 Dahl-
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SS that exhibited symptoms consistent with stroke. Hemorrhagic lesions were 
present in the cerebrum in all 7 out of 39 rats. One rat had hemorrhagic lesions 
in both the cerebrum plus the cerebellum and brainstem. Brain sections from the 
latter rat that were stained with cressyl violet are shown in Figure 3. 
Five of 6 rats demonstrated focal areas of extravasation of Evans blue dye 
in the c1erebrum and the remaining rat exhibited a general extravasation of the 
dye. Figure 4 demonstrates focal areas of Evans blue extravasation surrounded 
by lighte~r areas of edema surrounding the extravasated dye. 
To further confirm the presence of edema the wet to dry weight ratio of 
brains was measured in Dahi-SS that exhibited stroke-like behaviour (n=5) and 
compan~d to the ratio found in asymptomatic Dahi-SS fed 8.7% NaCI for 2 weeks 
and Dahi-SR fed 8.7% NaCI for 5 weeks. The results of these experiments are 
shown in Figure 5. Dahi-SS exhibiting stroke-like behaviour had brains 
containing a higher percentage of water than either asymptomatic Dahi-SS or 
Dahi-SR. This latter finding is consistent with the occurrence of brain edema in 
the Dahii-SS exhibiting stroke-like abnormal behaviour. 
A.t this point we concluded that the results suggest that the stroke-
like behavioural symptoms observed best represent the development of 
hypertensive encephalopathy rather than true stroke. By definition, stroke is 
produced by cerebral lesions secondary to the presence of brain ischemia or 
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Figure :~. A representative picture of brain (coronal section) from a Dahi-SS fed 
8.7% NaCI for 3.5 weeks that exhibited behavioural symptoms consistent with 
stroke. Brain stained with cressyl violet blue. The sites of hemorrhage within the 
cerebrum and brainstem are visible as red stained material. 
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Figure 4: Evans blue extravasation in the brain of a Dahi-SS exhibiting seizures 
with behavioural abnormalities exhibited blood brain barrier disruption and the 
extravascular movement of Evans blue dye (arrows). The light colored areas 
surrounding the extravasated dye correspond to areas of edema. Cerebral 
ischemia was absent and hemorrhage rarely occurred (7 /39) rats. Based on the 
brain pathology the behavioural dsyfunctions observed best represent the 
occurrence of hypertensive encephalopathy. 
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Figure 5: Levels of brain edema assessed by the water content of brains 
sampled from asymptomatic, post-HE Dahi-SS and Dahi-SR fed high salt (8.7% 
NaCI). The level of water content in the brains of Dahi-SS exhibiting "stroke-like" 
behaviour was significantly elevated when compared to asymptomatic Dahi-SS 
and Dahi-SR. Stroke is defined as the occurrence of neurological based 
abnormalities that result from a cerebrovascular accident which produces brain 
ischemia and or hemorrhage. Based on the absence of any evidence of brain 
ischemia and low incidence of cerebral hemorrhage combined with clear 
evidencE3 of brain edema and blood brain barrier disruption we concluded that 
"stroke-like" symptoms observed in our colony of Dahi-SS best represents a 
condition of hypertensive encephalopathy as apposed to true stroke. Therefore, 
from this point on in the thesis Dahi-SS exhibiting "stroke-like" behaviour will be 
referred to as having hypertensive encephalopathy (HE) as apposed to stroke. 
Statistics: ANOVA with Fisher post-hoc test. Significance was determined at (*) 
P<0.05. Values represent the mean± SEM (all groups had 5 animals per group). 
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hemorrhage. In view of the near absence of the latter forms of lesions it is 
incorrect to define the current colony of Dahi-SS as having stroke based only on 
the presence of behavioural symptoms. 
Based on the above conclusion from this point to the end of the 
thesis, Dahi-SS exhibiting hypertensive encephalopathy (HE) will be 
referred to as post-HE as apposed to rats with stroke or stroke-like 
behavi(>Ur. 
2.4.3 An Analysis of Renal Function in Dahi-SS and Dahi-SR Fed High Salt 
Alterations in the plasma levels of urea (blood urea nitrogen-BUN), 
creatinine and albumin are outlined in Figure 6. Plasma BUN and creatinine 
were si~~nificantly elevated in post-HE Dahi-SS fed 8.7% NaCI (for 3.5 weeks) 
and their plasma compared to the asymptomatic Dahi-SS fed the same diet (for 2 
weeks). In Dahi-SR fed 8.7% NaCI (for 5 weeks), which do not develop HE, 
similar plasma levels of BUN and creatinine are observed in comparison to 
asymptomatic Dahi-SS fed high salt. Plasma albumin was significantly lower in 
the post-HE Dahi-SS compared to asymptomatic Dahi-SS rats. Proteinuria was 
assesse!d by determining urinary protein loss in relation to the creatinine 
clearance over a 24-hour period. This parameter represents an estimate of the 
level of protein loss into urine in relation to glomerular filtration. As shown in 
Figure 7, the urinary 
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Figure 6: Blood plasma profile of urea (BUN), creatinine and albumin in 
asymptomatic Dahi-SS, post-HE Dahi-SS and Dahi-SR fed 8.7%NaCI. Post-HE 
Dahi-SS were fed a 8.7% NaCI diet for 3.5 weeks. Dahi-SR were fed a high salt 
diet for 5 weeks whereas asymptomatic Dahi-SS received the diet for 2 weeks. 
Statistics: ANOVA with Fisher post hoc. BUN and creatinine and albumin values 
were sig1nificantly different between post-HE Dahi-SS and asymptomatic Dahi-SS 
and SR groups, (*) P<0.05. Values represent the mean ± SEM (asymptomatic 
Dahi-SS=11, post-HE Dahi-SS=16 and Dahi-SR=5. 
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Figure "l: An analysis of proteinuria in asymptomatic Dahi-SS fed 0.7% or 8.7% 
NaCI diE~ts and Dahi-SR fed an 8.7% NaCI diet. The results show that urinary 
protein excretion per creatinine clearance was significantly elevated in Dahi-SS 
fed 8.7°A'o NaCI for 2 weeks when compared to Dahi-SR fed a 8.7% NaCI diet and 
Dahi-SS fed a 0.7% NaCI diet. Statistics: ANOVA with Fisher post-hoc. (*) 
P<0.05. Values represent the mean± SEM (all groups had 5 animals per group). 
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protein ~~xcretion per creatinine clearance was 9-fold higher in the asymptomatic 
Dahi-SS fed 8.7% NaCI (for 2 weeks) when compared to the Dahi-SS fed 0.7% 
NaCI (for 12 weeks) or Dahi-SR fed 8.7% NaCI for 5 weeks. 
2.4.4 Plasma Aldosterone Levels 
Figure 8 outlines the changes in plasma aldosterone levels in relation to 
diet (8 .. ?% versus 0.7% NaCI), strain (Dahi-SS versus Dahi-SR rats) and HE 
development in the Dahi-SS. Our results indicate that plasma aldosterone levels 
were si~1nificantly lower in asymptomatic Dahi-SS fed 8.7% NaCI (for 2 weeks) in 
comparison to Dahi-SS fed 0.7% NaCI for 12 weeks. 
Post-HE Dahi-SS fed 8.7% NaCI (for 3.5 weeks), had high plasma 
aldosterone levels. The level of plasma aldosterone in these rats was 4 times 
higher than that presented in asymptomatic Dahi-SS and double of that observed 
in Dahi-SS rats fed a normal diet (Figure 8). Dahi-SS fed 8.7% NaCI (for 3.5 
weeks) and subjected to captopril (50 mg/kg/day) treatment that developed HE 
had half the levels of plasma aldosterone observed in untreated age matched 
Dahi-SS with HE. The level of plasma aldosterone observed in captopril treated 
Dahi-SS with HE was equal to that present in asymptomatic Dahi-SS fed normal 
NaCI. 
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Figure 8: Effect of an 8.7% NaCI and 0.7% NaCI diet on plasma aldosterone 
levels in asymptomatic and post-HE Dahi-SS rats in comparison to Dahi-SR fed 
high (8.7%) and normal (0.7%) NaCI and post-HE Dahi-SS fed high salt along 
with captopril (50mg/kg/day) treatment. Plasma aldosterone levels in post-HE 
Dahi-SS were significantly elevated when compared to all other groups (*) and 
the levels in Dahi-SS (normal salt) were significantly higher than both 
asymptomatic and post-HE Dahi-SS rats (+). Statistics: ANOVA with Fisher post-
hoc test. Significance was determined at P<0.05. Values represent the mean ± 
SEM (asymptomatic Dahi-SS=6, post-HE Dahi-SS=8, Dahi-SS normal salt=? 
Dahi-SS +captopril=3, Dahi-SR high salt=5 and Dahi-SR normal salt=1 0). 
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2.5 DISCUSSION 
Dahi-SS fed 8. 7% NaCI rapidly developed high blood pressure levels (> 
200 mmHg) that were eventually associated with neurological abnormalities 
(such as seizures, convulsive repetitive forearm movements and altered posture) 
and behavioural abnormalities consisting of poor grooming and lethargy. All 
Dahi-SS that were not sampled at the time when these abnormalities were first 
observed died within 1 day. The brains of the rats showed no evidence of 
ischemia and the observation of intracerebral hemorrhage was rare. Both brain 
edema and BBB disruption was observed in Dahi-SS that developed neurological 
and behavioural abnormalities. Evidence of these alterations was demonstrated 
by the extravasation of Evans blue dye and by an increase in brain water 
content. Alterations in renal function occurred in Dahi-SS fed high salt. Dahi-SS 
exhibiting neurological and behavioural abnormalities had higher levels of plasma 
aldosterone compared to Dahi-SR fed high salt. These animals also developed 
uremia and significant elevations in plasma creatinine. Plasma albumin levels 
were decreased and proteinuria was observed in the rats. 
2.5.1 DEwelopment of Hypertensive Encephalopathy 
Our working hypothesis was that the neurological and behavioural 
abnormalities observed in Dahi-SS fed 8. 7% NaCI were due to stroke. However, 
in the present study, Dahi-SS exhibiting stroke-like behaviour were completely 
devoid of ischemic areas (indicated by bright red staining of the brain slices in 
53 
response to TTC). In addition, histological evaluation using GFAP staining 
revealed a complete absence of GFAP reaction (which accumulates in astrocytes 
after ischemic damage). These assessments indicate that the stroke-like 
behaviour was not a result of ischemic brain damage. Intracerebral hemorrhage 
formation in Dahi-SS exhibiting stroke-like behaviour was rare and occurred in 
less than 20% of the brains examined. Since by definition stroke is produced by 
brain ischemia and or hemorrhage (Sacco and Mayer, 1994) behavioural 
abnormalities observed in Dahi-SS fed 8.7% NaCI were not the result of stroke. 
Vve believe that the stroke-like behavior observed in Dahi-SS was a result 
of the development of HE. HE is neurological dysfunction brought about by a 
sudden rise in BP that has been primarily described in humans (Vaughan & 
Delanty, 2000). It occurs in the absence of cerebral ischemia or hemorrhage and 
produces stroke-like symptoms such as lethargy, confusion, headache, visual 
impairments and generalized seizures (Healton eta/., 1982; Vaughan & Delanty, 
2000). HE is associated with a loss in CBF autoregulation in response to the 
rapid rise in BP (Dinsdale, 1982; Vaughan & Delanty, 2000). This promotes a 
breakdown in the BBB (Oztas & Turkel, 2001) that is coupled with fluid 
movement into the extravascular space and cerebral edema formation (Vaughan 
& Delanty, 2000). The occurrence of BBB breakdown and HE development is 
dependEmt on the level and duration of hypertension present and is potentiated 
by a sudden abrupt elevation in blood pressure (Sokrab eta/., 1988; Johansson, 
1999). 
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All the above alterations (motor dsyfunctions, seizures, BBB breakdown, 
brain edema in the absence of cerebral ischemia or hemorrhage) associated with 
HE deVE3Iopment in humans are consistent with the changes observed in Dahi-
SS from the present study. The development of such alterations at the first point 
where maximal hypertension was established in our colony of Dahi-SS (4 to 5 
weeks salt feeding) just after the phase of rapid hypertension development is 
consistent with the characteristics of HE development in humans. In view of the 
similarities in characteristics of HE development in humans and our observations 
in Dahi-SS we believe that our rats best represent a model of hypertensive 
encephalopathy. This in itself is important since no animal model that develops 
HE in a reliable fashion is currently available for study. BBB breakdown in Dahi-
SS rats with HE was exclusively observed in the cerebrum. This may give insight 
into the particular behavioural abnormalities (seizures and involuntary limb 
moveme1nt) that these rats exhibited since the cerebrum is primarily involved in 
regulating motor control. 
Cerebral edema may by virtue of applying intracranial pressure, disrupt 
the medullary control and/or cortical of heart function creating the potential for 
cardiac arrhythmias to occur (Hachinski, 1993; Oppenheimer, 1994). This type 
of pathway connecting hypertensive BBB disruption to heart dysfunction may 
have caused our Dahi-SS rats to die abruptly after HE development. 
In other studies Dahi-SS fed high salt tended to develop both cerebral 
hemorrhage and ischemia (Tobian eta/., 1985; Werber eta/., 1985; von Lutterotti 
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eta/., 1 B92; Lin eta/., 1999; Zhang eta/., 1999). However in our colony of Dahi-
SS observations of hemorrhages were rare and there was an absence of 
ischemia following high salt feeding. This low propensity for stroke development 
in our model compared to others may have been due to genetic differences 
between Dahi-SS colonies. The observation of predictable HE development 
within our colony of Dahi-SS in response to high salt feeding may be of greater 
value than a situation where the rats uniformly developed stroke since at the 
present time no animal model of HE exists. 
2.5.2 RE~nal Function During Hypertensive Encephalopathy 
The kidneys of Dahi-SS with hypertension undergo changes in 
morphology that modify kidney function (Rapp & Dene, 1985; Sterzel eta/., 1988; 
Karlsen et a/., 1997). A morphological assessment of renal structural alterations 
was not the objective of this study. However, we did histologically section and 
_stain (H & E) four kidneys from Dahi-SS with HE. These sections exhibited 
vascular and glomerular degeneration as well as the appearance of fibrinoid 
deposits in renal arterioles and capillaries. The presence of these lesions would 
decrease blood flow resulting in reduced glomerular filtration (Hirawa et a/., 
1997). A reduction in glomerular filtration would facilitate the production of 
uremia and exacerbate the development of hypertension due to volume 
expansion via salt and water retention. 
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Certain characteristics of renal dysfunction could potentiate HE 
development in Dahi-SS. The excess loss of protein into the urine (proteinuria) 
and the associated decreased plasma albumin could decrease colloidal osmotic 
pressure and promote edema formation throughout the vasculature. Post-HE 
Dahi-SS from the current study also exhibited massive fluid accumulation within 
.·the abdominal cavity (ascities) suggesting that global non-cerebral movement of 
fluid into extravascular space occurred. The development of proteinuria could be 
important in promoting HE development since asymptomatic Dahi-SR fed high 
salt fail to develop proteinuria and maintain plasma albumin levels that are 
equivalent to those observed in Dahi-SS fed normal salt. 
Humans exhibiting end-stage renal disease (i.e. uremia, proteinuria, blood 
in the urine and abnormal electrolyte levels) also commonly show signs of HE 
(Agildere eta/., 2001). It has been suggested that an inability of the kidney to 
control fluid homeostasis results in a rapid elevation of blood pressure as 
glomerular filtration is significantly reduced (Agildere et a/., 2001). Such 
individuals also commonly develop proteinuria, hence it is possible that a drop in 
plasma oncotic pressure may also aggravate brain edema formation and HE 
development. 
2.5.3 The Effects of ACEis on the Development of Hypertensive 
Encephalopathy 
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The beneficial effect of captopril in both protecting and treating the onset 
·of strok~e has been demonstrated in the SHRsp (Stier et a/., 1991; Macleod et 
a/., 199~r). The mechanisms by which captopril exerted its anti-stroke effect was 
postulated to be through the reduction in plasma aldosterone levels (Macleod et 
a/., 1 99~r) possibly by decreasing the development of kidney and cerebral lesions 
(Stier et a/., 1991 ). 
Evaluation of plasma aldosterone in the present study revealed that 
plasma aldosterone was significantly elevated in post-HE Dahi-SS compared to 
.asymptomatic Dahi-SS fed 8.7% NaCI for 2 weeks. However, the aldosterone 
levels observed in post-HE Dahi-SS were significantly lower than the levels 
observed in the post-stroke SHRsp (700 pmol/l versus 4000 pmolll respectively) 
(Macleod eta/., 1 997). 
As discussed within the literature review, renin release and consequently 
ANG II formation and plasma aldosterone levels are controlled by tubular urine 
flow and urine NaCI concentration at the macula densa. In high salt fed SHRsp 
and Dahi-SS, two opposing factors will govern renin release. Renal pathology 
develops causing a restriction in renal blood flow and glomerular filtration. This 
reduces primary urine production and flow past the macula densa and facilitates 
renin release. The latter effect is opposed by high salt ingestion which should 
increase the urinary Na levels passing the macula densa and in doing so reduce 
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the release of renin into the blood. It is the balance of these two opposing forces 
that will ultimately govern the level of renin release into the blood. It is possible 
since Dahi-SS were fed an 8.7% NaCI diet that the balance favored a lower renin 
release than that observed in SHRsp fed 4% NaCI diet. Therefore, although 
plasma levels of aldosterone elevated, the levels observed in SHRsp were not 
achieved in Dahi-SS fed high salt. 
Other factors may also govern the above balance. Dahi-SS exhibit far 
greater renal dysfunction and kidney ischemia than SHRsp when they are fed a 
high salt diet. In order for renin to enter the circulatory system it must flow 
through the glomerular capillaries into the venous circulation. If total renovascular 
occlusion occurred blocking this circulation, any potential renin released into the 
preglomerular arteriolar lumen will not make its way into the circulation. This 
would lead to the production of lower blood ANG II levels and consequently a 
smaller release of aldosterone from the adrenal gland. Finally, it is possible that 
the levels of renin release in response to Na+ concentration and urine flow may 
be set in a manner where the level of renin released per equal level of stimulation 
is less in the kidneys of Dahi-SS versus SHRsp. At the present time sufficient 
experimental evidence supporting or contradicting the above theories is not 
availabl13. 
High plasma aldosterone levels play an important role in the specific 
development of intracerebral hemorrhage. In this regard the absolute plasma 
aldosterone levels observed in post-HE Dahi-SS are comparable to levels found 
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in SHRsp treated with captopril that are protected from hemorrhagic stroke 
development and are below the levels observed in prestroke SHRsp not treated 
with captopril (Macleod et a/., 1997). Hence, if one accepts the premise that 
aldosterone plays a specific role in cerebral hemorrhage formation, the low 
aldosterone levels observed in asymptomatic and post-HE Dahi-SS may account 
for the low incidence of this lesion in this strain. 
In this study, captopril (50mg/kg/day) treatment produced no 
antihypertensive effects and did not delay the onset of mortality in Dahi-SS fed 
high salt. Dahi-SS fed high salt plus captopril treatment exhibited significant 
levels of hypertension and no change in HE-associated mortality. If elevated 
levels of plasma aldosterone play an important role in hemorrhagic stroke 
development and the subsequent death in SHRsp, it is reasonable to assume 
that since the levels of plasma aldosterone were not elevated to the same degree 
in post-HE Dahi-SS, captopril treatment and aldosterone suppression would not 
alter HE development. The ineffectiveness of captopril treatment in altering HE 
development and mortality in Dahi-SS would also indicate the mechanisms 
promoting death in this model do not involve the activation of the renin 
angiotensin system. However, one could speculate that if mortality after HE could 
be delayed in Dahi-SS the level of aldosterone might continue to rise and the 
incidence of hemorrhage formation in Dahi-SS would increase. 
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2.6 CONCLUSIONS 
Dahi-SS develop significant rapid renal insufficiency in response to a high 
salt diet: (8.7% NaCI). Established hypertension (> 200 mmHg) occurs by two 
weeks. This promotes the development of cerebral edema and HE, subsequently 
leading to death 1 day after initial observations of behavioural abnormalities 
associated with HE. The cellular mechanisms underlying the development of HE 
need to be addressed further to better understand the development in the Dahi-
SS model. It has been shown previously that HE is associated with the loss of 
cerebral blood autoregulation (Dinsdale, 1983) promoted by the rapid elevation in 
blood pressure. This could lead to an overperfusion of the brain and facilitate 
edema formation. In the next chapter we will evaluate cerebral blood flow 
autoregulation in Dahi-SS in response to feeding high salt. 
CHAPTER 3 
ALTERATIONS IN CEREBROVASCULAR AUTOREGULATION AND 
MYOGENIC FUNCTION IN DAHL-SS 
3.1 lntrc>duction 
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CBF autoregulation is defined as the maintenance of constant CBF under 
conditions of varying blood pressures. (Paulson et a/., 1990). This mechanism 
ensures that the brain obtains adequate supplies of oxygen (Oz) and nutrients 
even when blood pressure falls below normal levels (Harder et a/., 2002). In 
situations where blood pressure is elevated (i.e. hypertension), the 
autoregulatory control of CBF acts as a protective mechanism. In hypertensive 
individuals the CBF versus BP autoregulatory curve is shifted to the right 
(Strand~Jaard & Paulson, 1995). This ensures that during periods of increased 
blood pressure, CBF remains constant and overperfusion is prevented 
(Strand~Jaard & Paulson, 1995). 
The shifting of the upper BP limit of CBF autoregulation to higher limits 
during periods of increased blood pressure is likely the result of vascular 
remodeling (i.e. decreased lumen and increased wall thickness) which causes 
increase!d vascular contractility (Heagerty et a/., 1993; As mar et a/., 1997). A 
displacement of CBF autoregulation to higher BP limits can also occur due to 
increases in sympathetic nerve activity, which commonly occur during 
hypertension (Edvinsson et a/., 1978; Paulson et a/., 1990). These rightward 
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displacements in the autoregulatory curve in response to increased BP may 
protect against overperfusion and subsequent hemorrhage occurrence (Smeda 
eta/., 1B99b). 
In humans exhibiting hypertension, CBF autoregulation is maintained 
during therapeutic treatments with Ca2+ channel antagonists (Gaab et a/., 1990). 
However, in animals, the administration of high doses of nimodipine (Ca2+ 
antagonist) abolishes CBF autoregulation (Gaab et a/., 1990) and promotes the 
extravasation of fluid and blood into the extravascular space when BP is raised. 
This su~1gests that loss of CBF autoregulation under hypertensive conditions has 
the potential to facilitate the development of edema and hemorrhages. 
It has been suggested that the development of hypertensive 
encephalopathy (HE) in humans, is promoted by the loss of CBF autoregulation, 
which could facilitate the formation of cerebral edema and increase the risk of 
~emorrhage formation (Dinsdale, 1983). 
3.2 OBJECTIVES AND HYPOTHESES OF STUDY 
The observations outlined in Chapter 2 demonstrated that Dahi-SS fed a 
high salt diet develop marked elevations in BP and behavioural signs consistent 
with HE. The development of HE occurred in a predictable manner. The purpose 
of the following study was to test the hypothesis that HE development in our 
colony of Dahi-SS was preceded by an inability of the cerebrovasculature to 
autoregulate constant CBF. An important mechanism thought to produce CBF 
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autoregiUiation is pressure dependent constriction (PDC) (Johnson, 1986). 
Elevations in blood pressure which potentially increase flow are counteracted by 
cerebrovascular constriction, which increases vascular resistance to flow and 
helps maintain CBF constant (Johnson, 1986). In view of the above, we tested if 
potential loss of CBF autoregulation in the middle cerebral artery (MCA) 
perfusion domain was associated with an inability of the MCAs to constrict in 
response to elevations in pressure. 
To test the above hypotheses we evaluated Dahi-SS fed 8.7% NaCI. 
Laser Doppler techniques were used to measure CBF autoregulation in the 
perfusion domain of the MCA prior to HE development. In separate experiments, 
distal segments of the MCAs were isolated from the brain and the ability of these 
arteries to constrict to elevations in transmural pressure was tested and related 
to both HE development and CBF autoregulatory function. 
3.3 MATERIALS AND METHODS 
3.3.1 Experimental Animals, Diet and Systolic Blood Pressure 
These experimental protocols are outlined in detail in chapter 2. 
Specifically a description of the Dahl Salt-Sensitive Colony and the breeding 
protocol is outlined in section 2.3.1. The development of the appropriate high salt 
diet used is outlined in section 2.3.2. The techniques used to measure blood 
pressure in the particular experimental groups are outlined in detail in section 
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2.3.4. The behavioural changes associated with the development of 
hypertensive encephalopathy are outlined in section 2.3.5. 
3.3.2 The Measurement of CBF Autoregulation 
Laser Doppler techniques were used to measure CBF. The rats were 
anesthetized with sodium pentobarbital (65mg/kg, i.p.) and a tracheal tube (PE-
250) was inserted into the airway and connected to a ventilator. Pure 02 was 
mixed with inspired air to produce a Pa02 of about 250 mmHg (>98% 
hemoglobin saturation). The left femoral artery and vein were catheterized with 
PE-50 ad PE-10 tubing respectively that were filled with lactate Ringer's solution. 
The animal's head was then immobilized in a stereotaxic device. The animal's 
temperature was measured with a digital rectal thermometer and maintained at 
37°C thmugh the use of a heating pad. The skull cap was exposed and a 2 mm 
hole was drilled into the cranium without breaking the dura. The hole was 
positioned in the MCA perfusion domain of the right cerebral hemisphere, 1 mm 
right of lateral bregma in the oculus sinister parietale bone at a point where the 
outside edge of the 2 mm hole was just medial to a bony ridge. The latter ridge 
(unnamed) runs from the orbital socket in a posterior direction and separates the 
oculus sinister temporale and pars squamosa bones that form the lateral skull 
surface. A laser probe (PF 403, Perimed, Jarfalla, Sweden) was lowered into the 
hole by a micromanipulator until it touched the dura without penetrating this layer. 
The CBF flux was monitored using a Perimed 4001 laser Doppler flow meter 
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(Perimed, Jarfalla, Sweden). Prior to the start of the experiments the laser probe 
was calibrated between fluxes of 0 to 250 using a PF1 00 Perimed external 
calibration standards. 
CBF was measured based on the fact that when laser light hits a moving 
object the wavelength of the light is (Doppler) shifted. In the brain, the laser 
beam penetrates the tissue. In vivo, only plasma is moving within the 
vasculature of the brain. The proportion of Doppler shifted light (reflected from 
the moving blood cells in the blood) in relation to the light hitting immobile matter 
was me~asured. A flux value was calculated which was proportional to the 
amount of blood flowing (velocity x blood cell concentration) below the probe. 
The BP of the animal was measured through a femoral arterial catheter, in 
which the catheter was connected to a Statham P23 ID pressure transducer 
(Gould Electronique, Ballainvillers, France) and amplified through a Gould Model 
81888 recorder containing a Universal amplifier. The BP and CBF flux were 
synchronized by an input into a computer and the analogue signals were 
converted to digital data (C10-AD 16 JR-AT, Acquire Program, Computer Boards 
Inc., Mansfield, MA, USA). The raw CBF flux and corresponding mean arterial 
blood pressure (MAP) data was stored in the computer as ASCII files. 
Following a equilibration period, blood PaC02 pH, HC03 and hemoglobin 
Oz saturation (Ciba Corning 278 Blood Gas System Analyzer, Medfield, MA, 
USA) were analyzed from an arterial blood sample collected from the femoral 
catheter (normal ranges; PaC02 >38 mmHg; pH 7.35-7.45; HC03 24-27mM and 
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hemoglobin 0 2 saturation >99%). The animal was then given an injection of 
hexamethonium (5 mg/kg, ip) to inhibit the sympathetic nervous system and 
prevent baroreflex action. This also typically lowered the animal's BP. The BP 
was then raised by infusing 4.6 x 1 o-2 mg norepinephrine/ml lactate ringers 
solution into the femoral vein via a syringe pump (Model 355, Sage Instruments, 
Cambridge, MA, USA) to produce a slow rise in BP. Norepinephrine was used to 
increase~ the BP since it can contract virtually all systemic blood vessels but has 
no effect on the vessels of the cerebrovasculature (Paulson et a/., 1990). Hence 
systemic BP can be raised without producing cerebrovascular constriction. 
In each experiment, BP was raised to the highest possible level. The CBF 
present at a given blood pressure was normalized to the CBF present at a MAP 
of 100 rnmHg to give a relative CBF value (i.e. relative CBF at a given MAP = 
"(Flux at the MAP/Flux at a MAP of 100 mmHg)). The relative CBF was then 
plotted against MAP. 
3.3.3 Pressure Myograph Studies 
The PDC was determined in MCAs of Dahi-SS fed 8. 7% NaCI prior to and 
followin~~ the development of behavioural symptoms consistent with the 
development of HE. In addition, we also sampled MCAs from Dahi-SR fed both 
a high (B.?%) and normal (0.7%) NaCI diet. There were 5 animals in each group. 
Isolated MCAs segments were examined for the presence of a functional PDC 
response using a pressure myograph apparatus described by Osol and Halpren 
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(1985). Briefly, rats were anaesthetized with sodium pentobarbital 
(65mg/Kg/i.p.). The thoracic cavity was opened to allow access to the heart. 
The left ventricle was cut to exsanguinate the animal. Following this, the skull 
cavity was opened and the brain was removed and placed in ice cooled Krebs 
saline solution bubbled with 95%02/5%C02. An isolated arteriolar segment of 
the MCA was removed and canulated on a hollow glass micropipette (-20 11m 
tip) of the pressure myograph apparatus. The distal end was tied with 10-0 
suture creating a closed sac. Pressure was increased within the lumen of the 
artery through the connection of the proximal end of the micropipette connected 
to a Krebs saline filled reservoir. The reservoir was then connected to a gas 
cylinder (95%02/5%C02). The preparation bath, containing Krebs saline solution 
was oxygenated (95%02/5%C02). All drugs used in the study were applied to 
the exterior of the artery within the Krebs saline suffusing the artery. The outer 
diameter of the artery was viewed through a microscope system (Wild Leitz M3 
microscope, Wild Heerbrugg, Switzerland) and the dimensional changes were 
·recorded on videotape and measured at 322x magnification. 
Following an initial equilibration period of 30 minutes at 100 mmHg, the 
pressure was reduced to 0 mmHg for an additional six minutes. Solution within 
the vessel chamber was held constant at 37°C. The PDC response was 
recorded as the amplitude of vessel contraction following a rapid pressure 
increase to 1 OOmmHg over a four minute increment. Following an initial dilation 
(1sec after pressure was applied) the vessel contracted over the four minutes at 
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100 mrnHg. Figure 9 is a representative example of PDC in a MCA from an 
asymptomatic Dahi-SS rat. Maximal diameter of the vessel is recorded as the 
amplitude of vessel vasodilation following nifedipine (3 J.!M) application. 
3.3.4 Statistical Analysis 
\Ne used either a one-way analysis of variance (ANOVA) followed by 
Fisher post-hoc test or GLM multivariant analysis of variance (MANOVA) to 
determine if significant differences existed between groups of data. Results were 
considered significant at P<0.05. The mean ±the standard error measurement is 
shown in the data. N values in the PDC experiments always equal one MCA from 
one rat used. A more detailed description of the statistical analysis is outlined in 
section 2.3.9. 
3.4 RESULTS 
3.4.1 Blc>od Pressure and the Behavioural Symptoms of HE in Dahl-55 
Dahi-SS fed 8. 7% NaCI for > 3 weeks exhibited behaviour consistent with 
HE (described in chapter 2). Dahi-SS fed a normal 0.7% NaCI diet for up to ten 
weeks were asymptomatic and appeared healthy throughout the duration of the 
experimEmts. 
The blood pressure profiles of Dahi-SS fed either 8.7% NaCI or 0.7% NaCI 
are outlined in Figure 10. Dahi-SS fed high salt exhibited a rapid onset of 
hypertension (defined as systolic >150 mmHg) whereas Dahi-SS fed normal salt 
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Figure ~~- An example of the lumen diameter alterations occurring in a middle 
cerebral artery in response to a 100 mmHg pressure step. The artery was 
sampled from a asymptomatic Dahl salt-sensitive rat and equilibrated to 0 mmHg 
pressure~ for six minutes. This eliminates pressure dependent tone from the 
artery. Then the pressure was increased abruptly to 100 mmHg. Initially, one 
second after pressurization, prior to a significant engagement of pressure 
dependemt constriction (PDC), the arterial lumen expands. Subsequently PDC 
reduces the lumen size to a smaller diameter (which is dependent on the applied 
pressure). PDC was measured as the decrease in lumen diameter between 1 
and 240 seconds after the application of a 100 mmHg pressure step. The 
application of nifedipine to the artery produced maximal vasodilation. 
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Figure 110. The systolic blood pressure profile of Dahi-SS rats fed 8. 7% NaCI 
(n=6) and 0.7% NaCI (n=7). Dahi-SS fed high salt after weaning (5 weeks of age) 
exhibited a rapidly developing onset of hypertension after only one week. Dahi-
SS fed 0.7% NaCI diet for 9 weeks exhibited normotensive blood pressures. 
Values represent mean± SEM. 
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diet remained normotensive. Maximal systolic BP's were >200 mmHg after a 
three week period. Subsequently, some of the Dahi-SS fed a high salt diet 
began to exhibit behavioural signs of HE. Dahi-SS fed a normal diet for nine 
weeks typically exhibited normal to borderline hypertensive (150-165 mmHg) 
levels up to a maximal systolic blood pressure of 160 mmHg. This level of 
hypertension was not associated with any of the behavioural symptoms of HE 
observed in Dahi-SS rats fed a high salt diet. 
3.4.2 Alterations in CBF Autoregulation in Dahl-55 
Table 1 outlines the blood gas parameters for the groups of rats used in 
these autoregulatory studies. Through the control of respiratory rates and the 
administration of oxygen, arterial pC02 was maintained at normal levels and 
blood hemoglobin oxygen saturation was always greater than 99.6%. Blood pH 
and HC03 levels were normal and none of the parameters differed significantly 
between the groups studied. 
Table 2 summarizes the characteristics of CBF autoregulation observed in 
the rats.. All of the Dahi-SS rats fed 8. 7% NaCI for one week or 0. 7% NaCI for 
nine weeks exhibited an ability to autoregulate blood flow up to an upper mean 
arterial pressure limit of respectively 168±6 mmHg and 204±12 mmHg. One of 
the six rats fed 8.7% NaCI for two weeks and four of the six rats fed 8.7% for 
three weeks lacked the ability to autoregulate blood flow with varying blood 
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Table 1: The arterial blood gas characteristics of anesthetized 
asymptomatic Dahi-SS used in cerebral blood flow experiments. 
Dietary Weeks 
NaCI (%) On Diet 
8.7 1 6 
8.7 2 6 
8.7 3 6 
8.7 9 7 
Values= mean± S.E.M. 
PaC02 = arterial C02 tension 
PaC02 
n Blood pH (mmHg) 
7.42 ± 0.01 40 ±2 
7.38 ± 0.01 40 ±2 
7.40 ± 0.01 39 ±2 
7.42 ± 0.01 40 ±2 
Hb02 saturation = saturation of arterial blood hemoglobin with oxygen. 
Blood Hb02 
HC03 Saturation 
(mM) (%) 
26.5 ± 0.8 99.9 ±0.02 
23.9 ± 0.9 99.7 ± 0.05 
24.7 ± 1.0 99.7 ± 0.05 
26.1 ± 0.5 99.7 ± 0.05 
Statistics (AN OVA) -arterial blood pH, PaC02, HC03 and Hb02 saturation did not significantly 
differ betvveen groups. 
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Table 2: Characteristics of cerebral blood flow (CBF) autoregulation 
(mmHg) in anesthetized Dahi-SS. 
Dietary Weeks on Proportion of rats Upper BP MCBF/ 
NaCI {':Yo) Diet n exhibiting Limit of ~mmHg 
autoregulation Autoregulation 
8.7 1 6 6/6 168 ± 63 4.73 ± 1.17 
8.7 2 6 5/6 181 ± 9 9.2±1.13° 
8.7 3 6 2/6 206 ** 7.12 ± 0.94 
0.7 9 7 717 204 ± 12 5.41 ± 0.85 
Values= Mean± S.E.M. 
BP = mean arterial pressure 
MCBF/~mmHg =change in relative cerebral blood flow between BP's of 90 to 120 mmHg (x10-3). 
**the 2 of the 6 rats exhibiting CBF autoregulation had a upper BP limits of 227 and 185 mmHg 
Statistics·- ANOVA (Fisher post hoc) 
a- significantly different from rats on a 0.7% NaCI diet. 
b- significantly different from rats on a 8.7% NaCI diet for 1 week and rats on a 0.7% NaCI diet. 
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pressures. These defects in CBF autoregulation occurred in the rats prior to the 
development of any behavioural abnormalities suggesting HE. 
Representative examples of the CBF autoregulation (presence and 
absence) are outlined in Figure 11. This data was obtained from two Dahi-SS 
fed 8.7% NaCI. The rat demonstrating an ability to autoregulate CBF maintained 
a relatively constant CBF as mean BP was increased from about 63 mmHg to an 
upper BP limit of CBF autoregulation (188 mmHg). The elevation of the mean 
arterial pressure above this point resulted in an abrupt increase in CBF. The 
second animal exhibited a linear increase in CBF with mean arterial pressure and 
an absence of an upper pressure limit to autoregulation, suggestive of an inability 
to autoregulate CBF in response to increases in BP (Figure 11 ). 
The changes in relative CBF with varying arterial pressure in Dahi-SS fed 
a 8.7% NaCI diet for one, two and three weeks are outlined in Figure 12. The 
rats in these groups were healthy and demonstrated no observable behavioural 
signs of HE. The changes in CBF demonstrate that a majority of asymptomatic 
~ahi-SS fed a 8.7% NaCI diet for three weeks lose their ability to autoregulate 
CBF. Dahi-SS fed a 0.7% NaCI diet for nine weeks all maintained the ability to 
·_;:wtoregulate CBF (Figure 13). The CBF alterations in rats fed a normal salt diet 
were comparable to those observed in Dahi-SS fed 8.7% NaCI diet for two 
weeks. 
Although a majority (4 of 6) of Dahi-SS fed a 8. 7% NaCI diet for three 
weeks lacked the ability to autoregulate CBF, the relative changes in CBF 
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Figure '11: An example of the changes in relative cerebral blood flow (CBF) with 
mean blood pressure in anesthetized asymptomatic Dahi-SS exhibiting the 
presence and absence of CBF autoregulation. The curves represent experiments 
on two rats fed 8.7% NaCI for 3 weeks. Rats exhibiting CBF autoregulation 
exhibit very moderate changes in CBF up to the upper blood pressure limit 
termed breakthrough. In the absence of CBF regulation there is a linear increase 
in CBF with a blood pressure with no apparent breakthrough. In the absence of 
CBF autoregulation, the slope of the changes in relative CBF with respect to 
blood pressure will depend on the degree of vasoconstriction present in the 
cerebrovasculature. 
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Figure 112: Alterations in cerebral blood flow (CBF) autoregulation in 
anaesthetized asymptomatic Dahi-SS fed 8.7% NaCI for varying duration. Dahi-
SS fed 8.7% NaCI for 1 week from weaning (5 weeks of age) exhibited ability to 
autoregulate CBF. The majority of these rats (5/6) fed this diet for 2 weeks also 
exhibited an ability to autoregulate CBF and the upper limit of CBF autoregulation 
was shifted to higher blood pressure limits (see Table 2). The majority of 
asymptomatic rats (4/6) fed 8.7% NaCI for 3 weeks lacked an ability to 
autoregulate CBF and exhibited a linear relationship between CBF and blood 
pressure. Statistics: General Linear Model MANOVA on curves. Each curve is 
significantly (p<0.05) different from all other curves in absolute levels over 
common blood pressures and in terms of an interactive effect of relative CBF 
with blood pressure (p<0.05 in all cases). (n=6 rats in each group). 
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Figure '13. CBF autoregulation in anaesthetized Dahi-SS fed 0.7% NaCI. Rats 
(n=7) fed 0.7% NaCI from weaning (5 weeks of age) for 9 weeks maintained an 
ability to autoregulate CBF in a manner virtually identical to rats fed 8. 7% NaCI 
diet for :2 weeks (n=6). Statistics: General Linear Model MANOVA on curves: no 
significant differences were observed between groups. 
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between BP of 90 to 120 mmHg were comparable between the groups (Table 2). 
The Dahi-SS fed a 8. 7% NaCI diet that exhibited autoregulation had upper limits 
of CBF regulation which tended to be displaced to higher pressures in relation to 
duration of time that the rats on high salt diet. The upper limit of CBF regulation 
was high (204±12 mmHg) in Dahi-SS fed a normal salt diet despite the fact that 
these rats had near normal BP's. This observation suggests that factors other 
than elevations in BP also can lead to an elevation in the upper limit of CBF 
autoregulation in Dahi-SS. 
CBF autoregulation experiments were attempted on Dahi-SS with HE. 
Unfortunately after developing HE the rats became quite sick and were extremely 
vulnerable to death once they were anesthetized with sodium pentobarbital. All 
the animals studied in this condition died within the first 30 minutes of 
anesthesia. This time period was insufficient to conduct the autoregulatory 
protocol outlined. However, the observation that a majority of asymptomatic 
Dahi-SS lost the ability to autoregulate blood flow after being fed a high salt diet 
would suggest that defects in CBF autoregulation precede HE development and 
it is reasonable to believe that this dysfunction is maintained after HE 
development. 
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3.4.3 Alterations in Cerebrovascular Pressure Dependent Constriction In 
Dahl-55 
The percent decrease in MCA lumen diameter in response to a 1 00 
mmHg pressure step in the lumen diameter of MCAs sampled from Dahi-SS fed 
a 8.7% or 0.7% NaCI diet is shown in Figure 14. The ability to constrict in 
response to an increase in pressure declined in relation to the duration of high 
salt (8. 7'% NaCI) feeding in MCAs of Dahi-SS. This response was severely 
attenuated in rats subjected to the diet for three weeks. Post-HE Dahi-SS (which 
were fed a 8.7% NaCI diet for three or four weeks) had MCAs that did not 
constric1t to pressure. The pressure dependent constrictor response observed in 
the MCAs of Dahi-SS fed a 0.7% NaCI diet for nine weeks was comparable to 
that observed in rats fed a 8.7% NaCI diet for two weeks. 
The nature of the loss of PDC in the MCAs of post-HE Dahi-SS is further 
characterized in Figure 15. This figure demonstrates that asymptomatic Dahi-SS 
fed a 8.ir% NaCI diet for three weeks and post-HE Dahi-SS (fed the same diet for 
three or four weeks) have MCAs with reduced lumen diameters under maximally 
dilated conditions (3 1-1M nifedipine) when compared to Dahi-SS maintained on 
the diet for one or two weeks. The absence or attenuation of PDC in the MCAs 
of post-HE Dahi-SS fed 8.7% NaCI for three weeks was associated with the 
maintenance of a very large degree of basal tone (calculated as % constriction in 
relation to the maximal dilated lumen diameter in response to nifedipine 3 !JM) 
and a reduced diameter at the start of pressurization (which would limit the 
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Figure '14: Pressure dependent constriction in the MCAs of Dahi-SS prior to 
and afte~r HE development. The percent decrease in the lumen diameter with 
respect to the time after the application of a 100 mmHg pressure step is shown. 
The MCAs of the Dahi-SS fed 8.7% NaCI for a period of 1, 2 or 3 weeks after 
weaning! (5 weeks of age) progressively developed a decreased ability to 
constrict in response to pressure. The ability to constrict to pressure was absent 
in MCAs sampled from post-HE Dahi-SS and was quite robust in Dahi-SS fed 
0.7% NaCI for 9 weeks. Statistics: General Linear Model MANOVA on curves: All 
curves were significantly different (p<0.05) from each other in terms of amplitude 
of the response with the exception of curve B vs E. All curves also significantly 
(p<0.05) differ from each other in terms of a differential interactive effect of 
response with respect to time, except for the following comparisons A vs B, A vs 
E, B vs E, C vs D. (n=5 rats within each group). Values represent mean± S.E.M. 
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Figure 115: The absolute changes in lumen diameter in response to pressure and 
nifedipine in MCA are sampled from Dahi-SS. The figure shows the lumen 
diameters present in MCAs 1 second after the application of 100 mmHg pressure 
prior to significant constriction in response to pressure and the lumen diameter 
present after 240 seconds at a time when pressure dependent constriction is 
complete. Subsequently nifedipine was added to the bath producing maximal 
dilation of the arteries. Under maximally vasodilated conditions (in the presence 
of nifedipine) there is a reduction in lumen diameter of MCAs from asymptomatic 
Dahi-SS fed 8.7% NaCI for 3 weeks and post-HE Dahi-SS (3 or 4 weeks on the 
diet) wh13n compared to Dahi-SS fed 8.7% NaCI for 1 or 2 weeks post weaning. 
Statistics: ANOVA plus Fisher post hoc test. Significant (p<0.05) differences: At 1 
second at 100 mmHg- A vs C, B vs C and D. At 240 seconds at 100 mmHg- B vs 
C and D. At 100 mmHg with nifedipine- A vs B, C and D, B vs C and D. (n=5 rats 
within each group). Values represent mean± S.E.M. 
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further ability of the MCAs to constrict to pressure). As shown in Figure 16, the 
degree of basal tone present in the MCAs increased with the duration of time the 
rats were maintained on high salt (8. 7% NaCI). We also evaluated Dahi-SS fed 
0.7% NaCI for 9 weeks. Data for these rats is not included in Figure 14 to 
increase~ the clarity of the figure. The MCA lumen diameters 1 second and 4 
minutes after pressurization to 100 mmHg and after maximal vasodilation to 3 f.!M 
nifedipine were respectively 190±14, 127±9 and 213±91Jm, mean± SEM (n=5 per 
group). These values were not significantly different from the same parameters 
in Dahi-SS fed a 8.7% NaCI diet for one week. The degree of basal tone present 
in Dahi-SS fed a 0.7% NaCI diet for 9 weeks was less than that observed in 
Dahi-SS fed a 8.7% NaCI diet for 3 weeks and not significantly different from rats 
fed high salt for 1 or 2 weeks (Figure 16). 
3.5 DISCUSSION 
The studies of this chapter were carried out to test the hypothesis that HE 
development was preceded by a defect in the ability of the cerebrovasculature to 
autoregulate CBF and to further assess the possibility that the latter defects 
coincided with the inability of the vascular segments to elicit constriction to 
pressure. Dahi-SS fed 8.7% NaCI developed behavioural symptoms consistent 
with HE. The origin of the symptoms likely resulted from the breakdown or loss 
in integrity of the BBB as evidenced by significant edema formation and 
extravasation of Evans blue dye, previously outlined in chapter 2 (Figure 7). A 
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Figure 116: The basal tone in MCAs of Dahi-SS at 100 mmHg prior to the 
initiation of pressure dependent constriction. The basal tone present in the MCAs 
prior to pressure dependent constriction was calculated as the percent 
constriction present from the maximally dilated state (i.e.[(lumen diameter 1 sec 
after pressurization to 100 mmHgllumen diameter in presence of nifedipine at 
100 mmHg)-1] x 100. Statistics: ANOVA plus Fisher post hoc test. Significant 
(p<0.05) difference A vs C and D, B vs C and D, D vs E (n=5 rats within each 
group). Values represent the mean± S.E.M. 
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key finding in the present study was that the ability of the MCAs to constrict to 
increases in pressure (i.e. the PDC response) decreased in relation to the 
duration that the rats were fed high salt. This response was absent in MCAs 
sampled from rats exhibiting HE. Conversely, the MCAs of Dahi-SS fed a 0.7% 
NaCI diet for 9 weeks continually exhibited robust constriction to pressure. 
Chronologically, the virtual loss of PDC in the MCAs of asymptomatic Dahi-SS 
fed a 8.7% NaCI diet coincided with the loss of CBF autoregulation in matched 
rats. This raises the possibility that a loss of cerebrovascular PDC may be an 
important mechanism contributing to the loss of CBF autoregulation. 
3.5.1 Characteristics of Cerebral Blood Flow Autoregulation 
The hypothesis that CBF autoregulation was lost prior to HE development 
was supported by the observation that asymptomatic Dahi-SS fed a 8.7% NaCI 
diet for 3 weeks showed an inability to regulate CBF (the relationship between 
blood pressure and CBF was linear). Interestingly, the change in relative CBF in 
respons1s to BP (Table 2) was similar between all groups despite the absence or 
the presence of autoregulation. The latter phenomenon could be explained by a 
situation where the loss of CBF autoregulation occurred in the presence of either 
a reduction in lumen diameter and/or vasoconstriction of the vessels. This 
potential mechanism is explained in detail in Figure 17. 
In addition, after 3 weeks of high salt feeding the lumen diameters were 
reduced in the MCAs of asymptomatic Dahi-SS fed high salt (see figure 15, C., 3 
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Figure 17: A hypothesis of the type of change occurring in the 
cerebrovasculature of asymptomatic Dahi-SS fed 8.7% NaCI for 3 weeks. The 
solid line curve labeled AUTOREGULATION represents the approximation of the 
average change in relative cerebral blood flow (CBF) with blood pressure in 
asymptomatic Dahi-SS fed 8. 7% an NaCI diet for one week. Evidence of CBF 
autoregulation with the presence of a distinct upper limit is present. The loss of 
CBF autoregulation under conditions of cerebrovascular vasodilation would 
produce hyper-perfusion at higher blood pressures, a straight line relationship 
without the presence of a distinct upper limit to autoregulation such as that 
shown in the figure (see LOSS OF AUTOREGULATION + VASCULAR 
DILATION). The occurrence of a loss of autoregulation and the presence of 
cerebrovascular vasoconstriction would decrease the slope of the relationship of 
relative CBF to blood pressure from that present under dilated conditions as 
shown iin the diagram (see LOSS OF AUTOREGULATION + VASCULAR 
CONSTRICTION). This is representative of the type of regulation present in the 
asymptomatic Dahi-SS fed 8.7% an NaCI diet for 3 weeks (see Figure 12). If the 
types of alterations observed in the isolated MCAs of Dahi-SS an fed 8. 7% diet 
are representative of the typical types of alterations in the cerebrovasculature. 
The loss of CBF autoregulation in rats fed the diet for 3 weeks could be due an 
ability to constrict to pressure, (see Figure 14) coupled with the development of a 
structurally reduced lumen diameter (see Figure 15) plus the presence of a large 
degree of basal tone (see Figure 16). This could exert a protective effect, 
preventing maximal cerebrovascular over perfusion under conditions where 
cerebral blood flow is lost. 
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1-1M nifedipine). This suggests that in addition to the presence of increased basal 
tone a structural reduction in the lumen diameter existed in asymptomatic Dahi-
SS fed high salt for 3 weeks. We believe that as hypertension continued to 
develop in Dahi-SS at approximately 3 weeks of high salt feeding, 
cerebrovascular PDC was attenuated causing the loss of CBF autoregulation. 
Autoregulation could have been lost under conditions of massive vasodilation. If 
this was the case it would result in a situation of overperfusion at higher blood 
pressun3s and a straight line relationship with no distinct upper limit as described 
by the curve (LOSS OF AUTOREGULATION+ VASCULAR DILATION) in Figure 
17. In this instance the change in CBF in relation to the change in BP would 
increase. In contrast, the loss of autoregulation in the presence of extreme 
vasoconstriction and/or a structural reduction in lumen diameter would create a 
linear rE3Iationship with a decreased slope in the relationship of relative CBF 
versus BP. This is best described by the relationship labeled "LOSS OF 
AUTOREGULATION+ VASCULAR CONSTRICTION" in Figure 17. 
Overall, the latter situation best represents autoregulatory characteristics 
observed in Dahi-SS fed 8.7% NaCI for 3 weeks (see Figure 12). This feature is 
also consistent with the presence of large degrees of basal tone (Figure 16), a 
structurally reduced lumen diameter (Figure 15) and an attenuation of PDC 
(Figure 14) in the MCAs of asymptomatic HE Dahi-SS fed high salt for 3 weeks 
and for post-HE rats. 
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3.5.2 Pr·essure Dependent Constriction and CBF Autoregulation 
In the microvasculature of the brain, pressure dependent constriction 
(PDC) is thought to play an important role in the autoregulation of blood flow 
(Johnson, 1986). Previous studies have shown that elevations in blood or 
transmural pressure under both in vivo conditions and in isolated cerebral 
vessels promote constriction in small cerebral arteries (Harder, 1984; Tamaki et 
a/., 1984; Faraci eta/., 1989). The constriction of cerebral vessels in response to 
elevations in blood pressure elevates vascular resistance to flow. This 
counteracts the subsequent potential increase in blood flow that might be 
expected to occur. Thus CBF remains constant despite the change in blood 
pressure. 
In the present study, MCAs from Dahi-SS fed high salt lost their ability to 
respond to increases in pressure (i.e. PDC) prior to the development of 
hypertensive encephalopathy. This loss in PDC was dependent on the duration 
that that animal was fed high salt. In Dahi-SS, there was a significant decrease(> 
80%) in the ability of the MCAs to constrict in response to a 100 mmHg pressure 
step when Dahi-SS were fed high salt from 1 week to 3 weeks. This suggests 
that changes are occurring within the vasculature that are altering the PDC 
response. The significance of this is that an inability to decrease lumen diameter 
in response to elevated pressure during hypertension could promote 
cerebrovascular overperfusion. The increased downstream pressure and 
elevated endothelial shear resulting from the loss of PDC could compromise the 
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blood-brain barrier and contribute to the initiation of HE. The 80% attenuation of 
the PDC in the MCAs of asymptomatic HE Dahi-SS fed high salt (Figure 14) is 
consistent with the observation that CBF autoregulation is lost in vivo in the MCA 
perfusion domain of comparable Dahi-SS fed high salt for the same duration 
(Figure 12). 
A potential limitation in studies evaluating PDC and CBF autoregulation in 
the MCAs perfusion domain is that it only provides a snapshot as to how the 
entire cerebrovasculature is responding to increases in pressure. In addition 
since the MCA is a relatively large vessel we do not know if the types of 
alterations that occur in the MCA mimic those present at the level of the 
microcirculation. That said, there is some consistency between the types of 
changes observed in the MCA and the nature of CBF autoregulatory loss 
observed, which suggests that a similar alteration exists in the microvessels fed 
by the MCA. 
3.5.3 Autoregulation: Dahl-55 versus 5HRsp 
The development of HE in Dahi-SS fed a high salt diet shows changes 
within the cerebrovasculature that exhibit similarities and contrasts to the types of 
changes present in the SHRsp following stroke development (Smeda, 1992; 
Smeda eta/., 1999b). Both Dahi-SS and SHRsp lost their ability to autoregulate 
CBF and developed defects in PDC within the MCAs prior to the development of 
stroke and HE. However, unlike Dahi-SS, the loss of autoregulation observed in 
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SHRsp was associated with an increase in c, CBF/ c,mmHg BP (Smeda et a/., 
1999b). The resultant effect of this relationship of CBF to BP was that 
overperfusion was enhanced to a greater degree than if regulation were lost 
under conditions of cerebrovascular vasoconstriction, (as is predicted in Dahi-
SS). This could explain the higher incidence of hemorrhage formation in SHRsp 
versus Dahi-SS. 
3.5.4 The Loss of Renal Blood Flow Autoregulation in the Kidneys of Dahl-
55 
Besides the present study, no other cerebral circulatory studies have been 
performed on Dahi-SS rats. However, it is of interest to note that similar 
alterations in autoregulatory dysfunction and defects in PDC have been noted in 
the renal vasculature of Dahi-SS (Karlsen eta/., 1997). As previously described, 
the kidney vasculature has the ability to regulate constant blood flow over a 
range of varying pressure under in vivo conditions. Studies involving isolated 
kidneys sampled from Dahi-SS have shown that elevations in renal perfusion 
produce constriction in the renal interlobular arteries and afferent arterioles 
(Takenatka et a/., 1992; Hayashi et a/., 1996). The response time to pressure 
elevations are faster in the renal versus the cerebral vasculatures but Ca2+ 
channel antagonists inhibit PDC in both vascular beds (Takenaka et a/., 1992; 
Hayashi eta/., 1996). Studies involving Dahi-SS rats fed an 8% NaCI diet for five 
weeks post weaning have indicated a complete loss in the ability of the renal 
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vasculature to autoregulate blood flow (Karlsen eta/., 1997). Likewise the loss of 
autoregulation was associated with the presence of a large increase in the renal 
vascular resistance to flow (Karlsen et a/., 1997), suggesting that the loss in renal 
blood flow autoregulation was associated with vasoconstriction and/or a 
structural reduction in the lumen diameter. Studies involving perfused kidneys 
have also indicated that Dahi-SS rats fed an 8% NaCI diet have interlobular 
arteries and afferent arterioles that lose their ability to constrict to pressure 
(Taken aka et a/., 1992; Hayashi et a/., 1996). It is possible that defects in the 
ability to autoregulate blood flow may occur in multiple vascular beds in Dahi-SS 
fed high salt diet. 
3.5.5 CONCLUSIONS 
Overall, we can conclude that the ability to constrict to pressure and 
regulate CBF is lost prior to the development of hypertensive encephalopathy in 
MCAs from post-HE Dahi-SS. The increase in basal tone observed in MCAs from 
post-HE Dahi-SS fed a 8.7% NaCI diet suggests that they lose their ability to 
autoregulate CBF under conditions of vasoconstriction. The loss of CBF 
autoregulation under conditions of cerebrovascular constriction would still result 
in a situation where in vivo alterations in BP would evoke changes in CBF, 
however, the presence of cerebrovascular constriction would provide some 
protection despite the loss of autoregulation by dampening the level of 
hyperperfusion during hypertension. This could account for the lower incidence of 
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cerebral! hemorrhage in this model in comparison to SHRsp, which lose CBF 
autoregulation under conditions of cerebrovascular vasodilation. The 
chronological, quantitative and qualitative changes in CBF autoregulation in the 
MCA pe1rfusion domain coincide with the loss of PDC in isolated MCAs perfusing 
this an3a suggesting that PDC is an important mechanism supporting 
autoregulation in these rats. 
CHAPTER4 
CEREBROVASCULAR ALTERATIONS IN PRESSURE AND PROTEIN 
KINASE C MEDIATED CONSTRICTION IN DAHL-55 
4.1 INTRODUCTION 
92 
The intrinsic ability of arterioles to rapidly constrict or dilate in response to 
an incre!ase or decrease in intraluminal pressure is defined as the myogenic 
respons~e or pressure dependent constriction (Meininger & Davis, 1992; Davis & 
Hill, 1999; Hill eta/., 2001). This mechanism provides the fundamental basis for 
regulation of blood flow within the cerebrovasculature that insures that the 
necessary nutrient and oxygen demand required for normal function is achieved 
(Harder et a/., 2002). In addition, it provides a protective mechanism whereby 
cerebrovascular overperfusion is prevented during hypertension (Strandgaard & 
Paulson, 1995). 
The signal transduction mechanisms linking elevations in pressure to 
arterial constriction have not been fully characterized. It is unlikely that one 
signalin~l pathway is responsible for mediating the PDC response. Both 
pharmac:omechanical (constriction without a change in smooth muscle 
membrane potential) and electromechanical (constriction associated with smooth 
muscle depolarization) coupled pathways are involved in producing PDC (Hill et 
a/., 2001) 
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Protein kinase C (PKC), modulates PDC during low levels of intracellular 
Ca2+ (Gokina et a/., 1999). PKC has also been shown to open voltage gated 
calcium channels (VGCC's) independent of membrane depolarization (Fish eta/., 
1988). In more recent studies, PKC activation in response to a cascade initiated 
by elevations in pressure have been hypothesized to open the transient receptor 
potential cation channels (TRPc). It was hypothesized that an influx of cations 
through TRPc's promoted vascular smooth muscle depolarization in the 
cerebrovasculature leading to the opening of VGCC's that lead to the initiation of 
constriction (Welsh et a/., 2002). All of the above evidence suggests that PKC is 
an important signal transduction agent and mediator of PDC in many arterial 
systems. 
The studies outlined in chapter 3 have demonstrated that PDC in the 
MCAs of Dahi-SS fed a high salt diet becomes attenuated prior to HE 
development and is lost in the MCAs of rats with HE. The loss of the PDC 
response in the MCAs of SHRsp with stroke was coupled to alterations in PKC 
function (Smeda et a/., 1999a). This suggested that the PKC system in the 
cerebrovascular smooth muscle plays an important role in governing PDC and 
that this system can become defective. In view of this, studies were carried out to 
determine if the loss of PDC observed in the MCAs of Dahi-SS exhibiting HE was 
. associa1ted with the presence of altered PKC function in the smooth muscle of the 
. 
arteries. 
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4.2 OBJIECTIVES AND HYPOTHESES 
It is our belief that PKC is an important signaling agent involved in 
promoting or permitting the development of PDC in the MCAs of Dahi-SS. We 
tested the hypothesis that the loss of PDC in the MCAs of Dahi-SS with HE was 
associated with the occurrence of defects in the ability of PKC to mediate MCA 
constriction. To test for this possibility, MCAs from Dahi-SS were sampled prior 
to and following the observation of behavioural signs associated with HE. The 
ability of MCAs from these rats to constrict to a 100 mmHg pressure step or to 
the PKC activator, phorbol dibutyrate was assessed. The ability of the artery to 
contract in response to pressure was related to the constriction produced by PKC 
activation. 
4.3 MATERIALS AND METHODS 
4.3.1 E)(perimental Animals and the Monitoring of HE Development 
These aspects of the experimental protocol are outlined in detail in 
chapter 2. Specifically, a description of the Dahl Salt-Sensitive Colony and the 
breed in!~ protocol is outlined in section (2.3.1 ). The rats were examined for signs 
of HE which are defined in section 2.3.5. 
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4.3.2 Pressure Myograph Experiments 
The evaluation of PDC was tested in the MCAs of Dahi-SS fed an 8.7% 
NaCI diet prior to (n=17) and following (n=1 0) the observations of symptoms 
consistent with the development HE. In addition, we also sampled MCAs from 
Dahi-SR fed 8.7% (n=10) and 0.7% (n=8) NaCI. Dahi-SR remained healthy and 
asymptomatic for the duration of the experiments when fed high or normal salt 
diet. PDC was measured in the MCAs using the techniques previously outlined in 
Chapter 3 (section 3.3.3) 
Following the evaluation of PDC to a 100 mmHg pressure step (methods 
describe~d earlier in detail in section 3.3.3), the MCAs were maintained at 100 
mmHg pressure and then maximally vasodilated with nifedipine (3 IJM). The 
PKC activator, phorbol dibutyrate (0.11-Jm) was applied to the bath (n=6) and the 
degree of constriction was measured. Validation experiments (outlined in the 
results section) were carried out which demonstrated that under the latter 
conditions constriction in response to phorbol dibutyrate was mediated by PKC 
activation, which was inhibited by the PKC inhibitors chelerythrine (12 IJM) or 
bisindoylmaleimide (5 IJM). MCAs were further evaluated in their ability to 
constrict to a 100 mmHg pressure step in the presence of the PKC inhibitors 
outlined above (n=4 per inhibitor). Control experiments evaluated the 
reproducibility of PDC in the presence of vehicle (50% dimethyl sulfoxide; n=4). 
In additional experiments (n=5), the ability of vasopressin (0.17 IJM) to constrict 
MCAs in the presence of 3 1-1M nifedipine was tested. Vasopressin can constrict 
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MCAs by the release of an intracellular source of Ca2+ in a manner independent 
of PKC activation. The presence of constriction in response to vasopressin 
indicated that the contractile apparatus remained functional. 
4.3.3 Statistical Analysis 
VVe used either a one-way analysis of variance (ANOVA) followed by a 
Fisher post-hoc test or GLM multivariant analysis of variance (MANOVA) was 
used to determine if significant differences existed between groups of data. 
Results were considered significant at P<0.05. The mean ±the standard error is 
shown in the data. N values always equal the number of rats used in the 
experiment. A more detailed description of the statistical analysis used is outlined 
in section 2.3.9. 
4.4 RESULTS 
4.4.1 Pressure Dependent Constriction 
MCAs sampled from Dahi-SS with HE were unable to constrict in 
response to a 100 mmHg pressure step (Figure 18). Asymptomatic Dahi-SS fed 
0.7% NaCI or 8.7% NaCI for 2 weeks as well as Dahi-SR fed 0.7% NaCI or 8.7% 
NaCI had MCAs that exhibited comparable and robust constriction in response to 
increase~s in pressure. 
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Figure 118: Pressure dependent constriction response in isolated middle cerebral 
arteries (MCAs) in response to a 100 mmHg pressure step. Rats were fed 8.7% 
or 0.7% NaCI from weaning (five weeks of age). Dahi-SS exhibiting behavioral 
signs of HE (n=1 0), had MCAs that did not constrict to pressure. Dahi-SR fed 
8.7% NaCI for 5 weeks (n=11) and asymptomatic Dahi-SS fed 8.7% NaCI for 2.0 
weeks (n=17) had MCAs that constricted robustly to the applied pressure. Dahi-
SS (n=11 0) and Dahi-SR (n=8) fed 0. 7% NaCI also constricted to pressure. 
Statistics: General Linear Model MANOVA: A vs B, C, D orE response over time 
p<0.05. Values represent the mean± S.E.M. 
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4.4.2 Pressure Dependent Constriction and PKC Activation 
The effects of the PKC inhibitors chelerythrine and bisindoylmaleimide on 
PDC and phorbol dibutyrate induced constriction in MCAs are outlined in Table 3. 
MCAs used in these experiments were sampled from asymptomatic Dahi-SS 
rats. As shown in Table 3 (1 51 PDC) arteries from these rats exhibited constriction 
in response to a 100 mmHg pressure step. Pre-incubation with 
bisindoylmaleimide or chelerythrine prevented the development of PDC in the 
MCAs (2nd PDC, Table 3) in response to a subsequent equal pressure step, and 
(in the presence of nifedipine (3 1JM) prevented constriction in response to 
phorbol dibutyrate (0.1 IJM). The effect of bisindoylmaleimide on the time course 
of PDC 1is shown in Figure 19. These data demonstrated that in MCAs, PDC can 
not occur under conditions where PKC activity is inhibited and that in the 
presence of nifedipine, phorbol dibutyrate mediates constriction by the activation 
of PKC. 
4.4.3 Alterations in the PKC System in Relation to the Development of 
Hypertensive Encephalopathy 
In separate MCAs, we assessed the function of the PKC system in 
asymptomatic Dahi-SS and Dahi-SR fed an 8.7% or a 0.7% NaCI diet as well as 
in Dahi-SS exhibiting HE (fed 8. 7% NaCI). MCAs of Dahi-SS with HE which were 
unable to constrict to a 100 mmHg pressure step (see Figure 18) also did not 
constrict to phorbol dibutyrate in the presence of nifedipine (i.e. via PKC 
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TABLE 3. Effect of PKC Inhibition on the PDC Response in MCAs of 
Asymptomatic Dahi-SS. 
PKC Inhibitor or 1st PDC (no 2nu PDC (+ PDB-mediated 
inhibitor or inhibitor or vehicle) Constriction 
V1ehicle vehicle) 
Control (n=5) -28.5 ± 2.4 -26.2 ± 1.7 -37.3 ± 6.4 
Vehicle (n=4) -24.8 ± 6.2 -31.0 ± 4.7 -25.0 ± 8.7 
Chelerythrine (n=4) -21.9 ± 2.9 +13.0 ± 5.5a 0 ± 0° 
Bisindollylmalemide -31.2 ± 4.2 -7.9 ± 5.6a -2.3 ± 1.3° 
(n=4) 
Values represent the mean± S.E.M. 
F~,b P<0.05 compared with all 1st PDC responses and all control and vehicle 
respons1es (ANOVA with Fisher's post hoc test). 
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Figure 19: The effect of PKC inhibition on PDC in isolated middle cerebral 
arteries MCA(s). PKC inhibitor bisindolylmaleimide (5 ~M) and chelerythrine (12 
~M) (see Table 1) significantly inhibited the ability of the MCAs to constrict to a 
100 mmHg pressure step. (n=4 asymptomatic Dahi-SS). Values represent the 
mean± S.E.M. 
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activation). On the other hand, the MCAs of asymptomatic Dahi-SS and Dahi-SR 
fed a hi~gh or normal salt diet exhibited constriction both to pressure (Figure 18) 
and to phorbol dibutyrate (Figure 20). 
Comparisons of the left versus the right MCA of the same rats indicated 
that Dalhi-SS with HE (which had MCAs that lacked the ability to constrict to 
phorbol dibutyrate) exhibited phasic constriction to vasopressin in the presence 
of nifedipine (see C versus F in Figure 20). Asymptomatic Dahi-SS and Dahi-SR 
had MCAs that constricted to both phorbol dibutyrate and vasopressin in the 
presence of nifedipine (Figure 20). 
4.5 DISCUSSION 
Dahi-SS fed an 8. 7% NaCI diet exhibited behavioural symptoms 
consistent with HE after three weeks of high salt feeding. Isolated MCA 
segments from these rats lacked a functional PDC response and could not 
contract to the PKC activator, phorbol dibutyrate in the presence of nifedipine. 
Pre-treatment with PKC inhibitors (chelerythrine and bisindoylmaleimide) 
abolishe!d the PDC response. The contractile apparatus of MCAs from post-HE 
Dahi-SS was functional since MCAs that were unable to elicit PDC could still 
constrict to vasopressin in the presence of nifedipine. 
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Figure :20. Constriction of isolated MCAs in response to phorbol dibutyrate or 
vasopressin in the presence of nifedipine. The experiment demonstrates that the 
MCAs of post-HE Dahi-SS that have an inability to constrict to pressure (See 
Figure "18) have a defective PKC system (see C). The inability to constrict in 
response to pressure or PKC activation is not due to a dysfunctional contractile 
apparatus since the isolated MCAs of post-HE Dahi-SS constrict in response to 
vasopressin (see F). (n-values, A-6 rats, B to F- 5 rats per group; different 
arteries were used for the phorbol dibutyrate and vasopressin constriction 
experiments. Statistics: ANOVA + Fisher post hoc- A vs C, B vs C, significant, 
p<0.01, A VS B -NS, D E and F are not significantly different (p<0.05) from each 
other. Values represent the mean± S.E.M. 
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4.5.1 Pt(C Signaling Pathway and Pressure Dependent Constriction 
The importance of PKC in the promoting vascular PDC has been 
demonstrated in a number of vascular beds (Osol et a/., 1991; Karibe et at., 
1997; Kirton & Loutzenhiser, 1998; Smeda et at., 1999a). Previous studies have 
evaluated the role of PKC in the signaling cascade that promotes PDC. In 
pressurized human coronary arterioles the maintenance of tone was dose 
depend~3ntly reduced when the PKC inhibitor, calphostin C, was administered 
(Miller e~t at., 1997). Furthermore, in vascular arterioles that lack the ability to 
constrict to pressure, the addition of the PKC activator phorbol 12-myristate 13-
acetate resulted in the establishment of a PDC response. (Miller eta/., 1997). 
Other experiments demonstrated that the PKC activator, indolactam 
enhanced the level of tone in rat posterior cerebral arteries when arteries were 
pressuri1zed to 125 mmHg whereas the PKC inhibitor, staurosporin, also 
produced a dose dependent vasodilation of (Osol eta/., 1991 ). 
Upstream signaling promoters of PKC may also be involved in initiation of 
PDC. Phospholipase C (PLC) activity within the smooth muscle membrane can 
lead to the formation of inositol triphosphate (IP3) and diacylglycerol (DAG) or 
DAG in the absence of IP3 (Narayanan et at., 1994). In pressurized rat posterior 
cerebral arteries the inhibition of PLC with U-73122 produced vasodilation (Osol 
eta/., 1 !393). In the latter study, the selectivity of U-73122 as a PLC inhibitor was 
validated by the attenuation of PLC mediated constriction in response to 5-HT. 
This suggested that vascular pressure induced constriction was mediated 
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through the activation of PLC. The latter hypothesis is consistent with the 
observation that the smooth muscle levels of DAG are elevated in dog canine 
renal arteries in response to elevations in pressure (Narayanan et a/., 1994). 
More recently, in human subcutaneous vessels, the inhibition of DAG kinase by 
the inhibitor, RHC-80267 abolished PDC (Coats et a/., 2001 ). These studies all 
suggest that the inhibition of PLC or the inhibition of downstream cellular 
components generated by PLC activation (i.e. DAG), inhibits the PDC response. 
These findings suggest that PLC activation may be involved in promoting PDC. 
4.5.2 P~CC Activation and the Downstream Signaling Promoting PDC 
The potential signal transduction pathway promoting PDC in response to 
PKC activation may involve the opening of the transient receptor potential 
channel (TRPc). These channels have been characterized in the smooth muscle 
of various vascular beds (Clapham eta/., 2001; Inoue et a/., 2001; Welsh et a/., 
2002). Hecently, mRNA coding for the TRPc6 channel was identified in smooth 
muscle cells of cerebral arteries. The inhibition of the TRPc6 channel with 
oligodeoxynucleotide antisense treatment inhibited pressure dependent but not 
high [K+]o depolarization induced constriction in posterior cerebral arteries (Welsh 
et a/., 2:002). It was hypothesized that elevations in pressure activated PLC, 
which (through a cascade of reactions) led to the formation of DAG. Increases in 
DAG activated PKC, which opened the TRP6 channels. The opening of these 
nonspecific cation channels produced vascular smooth muscle membrane 
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depolarization, which promoted the opening of VGCC leading to an influx of Ca2+ 
and myogenic contraction (Welsh et a/., 2002). The loss of PDC in the MCAs of 
post-HE Dahi-SS may be attributable to the fact that TRP6 channels are unable 
to open due to the presence of a defective PKC system. Since the MCAs of post-
HE Dahi-SS were capable of constricting to vasopressin (a response that is 
mediated by PLC activation), it is likely that the PLC component of the PDC 
signalin!~ pathway that precedes PKC activation (i.e. is involved in generating 
DAG) re1mained functional. Although the present study has demonstrated that the 
MCAs of post-HE Dahi-SS exhibit a defect in the ability to constrict to PKC 
activation, this does not preclude the possibility that other components in the 
pathway are also defective. Recent studies (Smeda, unpublished results) 
indicate that the MCAs of post-HE Dahi-SS exhibit an attenuated ability to 
constrict in response to high [K+]o induced depolarization, indicating that the 
mechanisms promoting the voltage dependent opening of VGCC's may also be 
defective in these arteries. 
Alternative signaling pathways have also been proposed to explain PDC in 
the cerebrovasculature of rats. An increase in pressure in rat cerebral arteries 
has been shown to increase the production of 20-hydroxyeicosatetraenoic acid 
(20-HETE), a cytochrome p450 metabolite of arachidonic acid (Gebremedhin et 
a/., 2000). The inhibition of 20-HETE formation or its vasoconstrictor action 
inhibits PDC in isolated rat cerebral arteries (Gebremedhin et a/., 2000). 
Constriction in response to 20-HETE is also thought to be promoted by PKC 
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activation and smooth muscle depolarization (via a decrease in K+ conductance, 
that promotes Ca2+ influx through VGCC) (Lange et a/., 1997; Gebremedhin et 
a/., 2000). If this unique signaling pathway is involved in promoting PDC in the 
cerebrovasculature, the presence of a defective PKC system would still lead to 
the inhibition of PDC. 
4.6 CONCLUSIONS 
There is overwhelming evidence that a functional vascular smooth muscle 
PKC system is necessary to allow PDC to occur in the cerebrovasculature. Our 
studies demonstrated that the inhibition of the PKC system in the vascular 
smooth muscle of MCAs inhibits PDC in the arteries. In addition we 
demonstrated that in the MCAs of Dahi-SS with HE, the loss of PDC coincides 
with the presence of a PKC system that is dysfunctional in terms of its ability to 
elicit constriction. Recent studies (Smeda & Payne, 2003) have indicated that 
there is a progressive decline in the ability of the isolated MCAs to elicit PDC in 
asymptomatic Dahi-SS fed an 8.7% NaCI diet for progressively longer durations. 
The ability of the MCAs of these rats to elicit PDC was directly related in a 
quantitative manner to the ability of the same arteries to constrict to PKC 
activation by phorbol dibutyrate (Smeda, unpublished results). Finally, virtually 
every pathway proposed to explain the signal transduction mechanisms 
promoting constriction in response to elevations in pressure have included PKC 
activation as an important, if not a critical, component. In view of the above 
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evidence there is a strong possibility that the presence of a defective PKC 
system may contribute to the loss of PDC in MCAs of Dahi-SS with HE. In view 
of the importance of cerebrovascular PDC in the maintenance of CBF 
autoregulation (discussed in Chapter 3), a defect in the vascular smooth muscle 
PKC system may contribute to the loss of CBF autoregulation observed in Dahi-
SS fed a high salt. 
CHAPTER 5 
ALTERATIONS IN CEREBROVASCULAR ENDOTHELIAL 
FUNCTION IN DAHL-55 
5.1 INTRODUCTION 
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Nlitric oxide (NO) is a potent vasodilator that is intrinsically produced in the 
vasculature. The basal release can occur from adventitial and endothelial 
sources in many vascular beds (Moncada et a/., 1991). The levels of NO 
released from the endothelium can be elevated by the actions of agonists that act 
on the endothelium to increase the activity of endothelial nitric oxide synthase 
(NOS). In addition, the endothelium very likely can release a non-NO dilatory 
factor such as endothelial-derived hyperpolarizing factor (EDHF) (Busse et a!., 
2002). Vasodilation can be evoked via the endothelial-mediated release of both 
NO and EDHF in response to stimulation by prostacyclins (Armstead, 1995), 
bradykinin and acetylcholine (ACh) (Faraci & Heistad, 1998). 
Endothelial functional impairment contributes to the development of 
hypertension (Boulanger, 1999). Endothelium dependent vasodilation is impaired 
in many models of both experimental and human hypertension (Luscher & 
Vanhoutte, 1986; Panza et a/., 1990). A reduction in vasodilation to ACh, 
methacholine, bradykinin and ADP has been observed in the 
cerebrovasculatures of SHRsp and SHR (Faraci & Heistad, 1998), whereas non-
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endothe,lial mediated vasodilation in response to nitroprusside (Baumbach et a/., 
1994) and adenosine (Mayhan eta/., 1987) remain un-impaired. 
t\litric oxide synthase (NOS) activity is altered in hypertensive Dahi-SS fed 
high salt (Chen & Sanders, 1993). The administration of L-arginine (a substrate 
that is broken down to produce NO by NOS) to Dahi-SS fed high salt reverses 
hypertension and improves renal hemodynamics (Mattson et a/., 1997), whereas 
NOS inhibition increases blood pressure (Chen & Sanders, 1993). In view of this 
it has been suggested that hypertension development in Dahi-SS may be 
partially maintained by the reduced production or decreased availability of NO 
(Hayakawa & Raij, 1998). 
5.2 OBJIECTIVES AND HYPOTHESIS 
There is a paucity of information regarding the development of 
hypertension and associated changes in endothelial function within the 
cerebrovasculature of Dahi-SS. Currently, it is unclear whether the basal release 
of endothelial and non-endothelial sources is altered in the cerebrovasculature of 
Dahi-SS with hypertension and the potential alterations in these functions in 
relation to HE or stroke development remain unexplored. In addition, no 
information is available as to whether NO released from the endothelium or the 
adventitia can modulate PDC in the cerebrovasculature of Dahi-SS. If such 
modulat1ion exists, it could have an impact on CBF autoregulation. 
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It is clear that NOS related-function is attenuated within the renal 
vasculature of hypertensive Dahi-SS (Chen & Sanders, 1993; Hayakawa & Raij, 
1998). Therefore, it is plausible that hypertension and or HE related alterations in 
endothelial function may impact the ability of cerebral arteries to elicit PDC. Dahi-
SS developed large degrees of basal tone in the MCAs following the 
development of HE (Chapter 3). This was not due to the presence of a circulating 
factor since these arteries were studies under in vitro conditions where they were 
suffused with a physiological saline solution. The lack of a circulating factor 
would suggest that the development of basal tone was intrinsic in origin. It is 
possible that elevations in basal tone could have occurred due to the attenuation 
of the basal release of NO from an adventitial and/or endothelial source or via the 
attenuation of the release of a non-NO endothelial derived vasodilator. 
The first objective of this study was to determine if the occurrence of HE in 
Dahi-SS was associated with changes in NOS-related function. The second 
objective was to assess if such changes altered the modulation of PDC in the 
cerebrovasculature? 
5.3 MATERIALS AND METHODS 
5.3.1 Animals 
A description of the Dahl Salt-Sensitive Colony and the breeding protocol 
is outlined in section (2.3.1 ). The techniques used to measure blood pressure in 
the particular experimental groups are outlined in detail in section (2.3.4). 
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5.3.2 Pressure Myograph Studies 
The evaluation PDC was tested in Dahi-SS (n=10 per group) fed an 8.7% 
NaCI diet prior to and following the development of behavioural symptoms 
consistent with the development of HE. The methodology for the evaluation of 
PDC was described in detail in chapter 3 (see section 3.3.3). All drugs used in 
the study were added to the external surface of the bath. 
5.3.3 A1:ssessment of the Effects of the Endothelium on Pressure Dependent 
Constriction 
MCAs were removed from the brains of Dahi-SS fed 0.7% NaCI (n=5) and 
mounted on to a pipette of the pressure myograph used to measure PDC within 
arteries. Prior to tying the arteries the arterial lumen of the proximal half of the 
artery was rubbed (15X) against the pipette tip to remove the endothelium. An 
intact endothelium was maintained on the distal end of the artery. Subsequently, 
the artery was tied on to the pipette and pressurized to 100 mmHg. Bradykinin 
(1.6 11MI) was used to evaluate completeness of endothelial removal in the 
proximal segments of the vessel. Using this technique the distal endothelial intact 
segment of the artery acted as a control for the proximal endothelial denuded 
segment. Vasodilation to bradykinin was also evaluated in MCAs from Dahi-SS 
fed 8.7% NaCI for 1 week (n=4) and Dahi-SS with HE (n=5) feed 8.7% NaCI for> 
3 weeks. The effects of NOS inhibition (1 00 11M L-NAME) on bradykinin 
.. 
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vasodilation was tested in MCAs sampled from asymptomatic Dahi-SS fed 8.7% 
NaCI for 1 week (n=4). 
5.3.4 Role of Nitric Oxide Synthase (NOS) in Modulating PDC 
PDC response to a 100 mmHg pressure step was measured in the areas 
of the MCA containing an intact and absent endothelium in the presence or 
absence of 100 1-1M L-NAME (i.e. NOS inhibition). The latter experiments were 
performed in MCAs sampled from Dahi-SS 0.7% NaCI for 9 weeks (n=5). The 
effects of L-NAME were also assessed in MCAs from Dahi-SS with HE (n=5) that 
were fed 8.7% NaCI. The MCAs were incubated with L-NAME for 10 minutes 
prior to the evaluation of its effects on PDC or vessel diameter. The specificity of 
NOS inhibition by L-NAME was evaluated in MCAs from Dahi-SS fed 0. 7% NaCI 
(n=4) by determining if the competitive inhibition produced by the NOS inhibitor 
could bta reversed by L-arginine (8 mM, the normal substrate for NOS). The 
specificity of the reversal of L-NAME inhibition by L-arginine was further tested by 
the inability of D-arginine (an incompatible substrate for NOS) to duplicate the 
effects of L-arginine. 
5.3.5 Statistical Analysis 
VVe used either a one-way analysis of variance (ANOVA) followed by 
Fisher post-hoc test, GLM multivariant form of analysis of variance (MANOVA) or 
student's t-test to determine if significant differences existed between groups of 
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data. Results were considered significant at P<0.05. The mean ±the standard 
error measurement is shown in the data. N values always equal the number of 
rats usE3d in the experiments. A more detailed description of the statistical 
analysis is outlined in section 2.3.9. 
5.4 RESULTS 
5.4.1 Pressure Dependent Constriction 
MCAs sampled from of Dahi-SS with HE (fed 8.7% NaCI) exhibited an 
attenuation of the PDC response to a 100 mmHg pressure step (Figure 21 ). 
Asymptomatic Dahi-SS fed 8.7% NaCI for 1 week displayed robust (>25%) 
constriction in response to pressure. 
Equal levels of PDC were observed in response to a 100 mmHg pressure 
step in the endothelial intact versus the denuded segments of MCAs that were 
sampled from Dahi-SS fed a 0.7% NaCI for 9 weeks (Figure 22). The denuded 
areas exhibited a greater vasodilation in response to nifedipine (3 ~-tM) when 
compared to the endothelial intact segments of the MCAs. Endothelial removal 
abolished the ability of bradykinin (1.6 ~m) to elicit vasodilation (Insert: Figure 
22). 
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Figure :21: MCA pressure dependent constriction in response to a 100 mmHg 
pressure step. MCAs were sampled from asymptomatic Dahi-SS fed 8.7% NaCI 
for 1 week and post-HE Dahi-SS fed 8.7% NaCI. Statistics: General Linear Model 
MANOVA post-HE Dahi-SS group significantly different from the asymptomatic 
group, p<0.01, n=1 0 per group. Values represent the mean± S.E.M. 
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Figure 2~2: Pressure dependent constriction in response to a 100 mmHg 
pressure step in MCAs from Dahi-SS (low salt diet) in which one area of the 
vessel was subjected to de-endothelialization. Insert: Endothelial removal was 
confirmed by the absence of vasodilation in response to bradykinin (1.6 1-1M). 
Statistics: General Linear Model MANOVA: Endothelium intact group not 
significantly different from endothelial denuded group, p>0.05, n=5 per group. (*) 
Student t-test -paired. Bradykinin relaxation was significantly different (p <0.05) 
between the endothelial intact and denuded segments, n=5 per group. Values 
represent the mean± S.E.M. 
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5.4.2 Endothelium-Dependent Vasodilation and Arteriolar Diameter 
Bradykinin mediated vasodilation was attenuated in (endothelial intact) 
MCAs sampled from Dahi-SS with HE (fed 8. 7% NaCI). The response was 
approximately 25% of that observed in the MCAs of asymptomatic Dahi-SS fed 
8. 7% NaCI for 1 week (Figure 23). Vasodilation to bradykinin was still observed 
after NOS inhibition (100 1JM L-NAME) in MCAs sampled from Dahi-SS fed 8.7% 
NaCI for 1 week indicating that significant a degree of endothelial dependent 
bradykinin vasodilation must be produced by a non-NO vasodilator (Figure 23). 
5.4.3 Modulation of PDC by the Endothelium and Nitric Oxide Synthase 
The endothelium intact MCAs of asymptomatic Dahi-SS fed 8.7% NaCI for 
1 week constricted to L-NAME (1 00 j..tM) indicating the presence of the release of 
basal NO. MCAs sampled from post-HE Dahi-SS exhibited an attenuated ability 
to const1rict in response to L-NAME (Figure 24) suggesting the possibility that the 
basal n3lease or action of NO may have been reduced. The level of 
vasoconstriction to L-NAME observed in asymptomatic Dahi-SS fed 8. 7% NaCI 
for 1 week was significantly lower than that observed in intact endothelial 
.segment's of MCAs from Dahi-SS fed a normal diet (Figure 24). In MCAs 
sampled from Dahi-SS fed 0. 7% NaCI, endothelial removal attenuated but did not 
abolish the ability of L-NAME to elicit vasoconstriction (Figure 24). This indicated 
that a non-endothelial source of basal NO release must be involved in promoting 
vasodilation in the MCAs (Figure 24). 
117 
c=J Dahi-SS (8.7% NaCI) Post-HE 
~ Dahi-SS (8.7% NaCI) Asymptomatic 
100 ~ Dahi-SS (8.7% NaCI) Asymptomatic +L-NAME 
80 
......... 
:::R 0 
-c 
0 
:;:::; 
C\l 
"0 60 0 
en 
C\l 
> 
C\l 
E 
·x 
C\l 
:2 40 
-0 
Q) 
C) 
* 
C\l 
-c 
Q) 
(.) 
..... 
Q) 20 c.. 
Figure 23: Endothelial mediated bradykinin vasodilation of MCAs sampled from 
Dahi-SS. The MCAs of asymptomatic Dahi-SS fed 8.7% NaCI for 1 week (n=4) 
and post-HE Dahi-SS fed 8.7% NaCI (n=9) were compared. The ability of NOS 
inhibition to inhibit bradykinin mediated vasodilation was assessed in the same 
MCAs that were sampled from Dahi-SS fed 8.7% NaCI for 1 week (n=4). 
Responses to 1.6 IJM bradykinin are shown. Statistics: ANOVA with post hoc 
Fisher t1est. Significant*, post-HE group vs asymptomatic and asymptomatic+ L-
NAME, p<0.05. Values represent the mean± S.E.M. 
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Figure :24: Effect of nitric oxide synthase (NOS) inhibition (1 00 !JM L-NAME) on 
the MCA diameter in arteries sampled from asymptomatic (n=4), post-HE Dahi-
SS (n=!i) fed 8.7% NaCI and Dahi-SS fed 0.7% NaCI. The effect of endothelial 
removal on L-NAME induced vasoconstriction was assessed in MCAs sampled 
from Dathi-SS fed 0.7% NaCI (n=4). Statistics: ANOVA with fisher post-hoc test. 
Significant *, post-HE group vs asymptomatic Dahi-SS group vs Dahi-SS 
endothelial intact group, +, asymptomatic Dahi-SS group vs Dahi-SS endothelial 
intact group p<0.05. Values represent the mean± S.E.M. 
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Table 4 outlines the effects of endothelium removal and NOS inhibition 
with L-I\IAME on PDC. MCAs used in the experiments were sampled from Dahi-
SS fed 0.7% NaCI (n=4). Endothelial removal did not alter the amplitude of the 
PDC response to 1 00 mmHg pressure step. However, the dimensional range 
over which constriction to pressure occurred was shifted to more constricted 
lumen diameters in the absence of endothelium (i.e. + endothelium from 195 ± 7 
1-1m at the start of PDC to 154 ± 7 1-1m at the end of PDC versus - endothelium 
140 ± 115 IJm at the start of PDC to 108 ± 13 IJm at the end of PDC). This 
indicated that although the endothelium is not involved in promoting PDC, the 
presence of an intact endothelium exerts a dilatory influence on the MCAs 
shifting the operating range of PDC to larger lumen diameters. If the dilatory 
influence of the endothelium was only mediated by the basal release of NO from 
the endothelium then it would be expected that after endothelium removal the 
subsequent addition of the NOS inhibitor, L-NAME would not alter arterial lumen 
dimensions. As shown in Table 4, this proved not be the case. After endothelial 
removal, L-NAME produced greater degrees of constriction. This indicated that a 
non-endothelial source of NO must have also been influencing basal tone in the 
MCAs. Finally, we assessed the possibility that the endothelium released a non 
NO vasodilator that was capable of influencing PDC and basal tone. IF 
endothelial and non-endothelial NO were the only source of vasodilatory 
influence in the MCAs and the endothelium produced no other vasodilator 
.capable of influencing basal tone then under conditions where NOS was inhibited 
120 
TABLE 4: Effect of L-NAME (100~M) on PDC in Intact and Denuded segments 
of MCAs of Dahi-SS 
Group 1s1 PDC 1s1 PDC 1sr PDC 2na PDC 2na PDC 2na PDC 
Start Finish (%) Start Finish (%) 
(~m) (~m) (~m) (~m) 
+ L-NAME +L-NAME +L-NAME 
Intact 
Endothelium 195 ± 7a 154 ± 7 -21.0b 146 ± 30 130 ± 22 
(n=4) 
Denuded 
Endothelium 140 ± 15 108 ± 13 -22.8b 106 ± 17 103 ± 16 
(n=4) 
Values represent the mean± S.E.M. 
a P<0.0!5 Lumen size at start of 1st PDC between intact and denuded segments. 
b P<0.0!5 Amplitude of 1st PDC versus 2nd PDC 
-10.9 
-2.8 
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, the subsequent removal of the endothelium would be inconsequential. As 
shown in Table 4 this was not the case. In the presence of L-NAME, endothelial 
removal further constricted the MCAs indicating that basal tone was influenced 
by a non-NO vasodilator that originated from the endothelium. 
A. shown in Table 4, the amplitude of the PDC in the MCAs was 
attenuated in the presence of L-NAME and further reduced when endothelium 
was removed during NOS inhibition. In out view, this observation could be 
misinterpreted to indicate that basal NO release (± endothelial non-NO 
vasodilatory influence) may be involved in promoting PDC. A more likely 
explanation of this phenomena is that the sequential abolishment of all basal NO 
influenc•e (via L-NAME) plus endothelial dependent non-NO effects (via 
endothe~lial removal in the presence of L-NAME) increases basal tone in the 
MCAs to a point where further constriction by other influences is limited. Hence 
the ability of pressure to induce further constriction is attenuated and the 
amplitude of PDC to a 100 mmHg pressure step is reduced (Table 4). 
Table 5 demonstrates that in MCAs sampled from Dahi-SS fed 0.7% NaCI 
(for 9 weeks), excess levels of L-arginine (SmM) or D-arginine (SmM) did not 
effect the ability of the MCAs to elicit PDC in response to a 100 mmHg pressure 
step. Pre-treatment with L-arginine but not D-arginine inhibited the ability of L-
NAME to induce vasoconstriction. Since L-NAME is a competitive inhibitor of 
NOS, the ability of high levels of L-arginine (the proper substrate for NOS) to 
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TABLE 5: Role of Arginine Isomers (LID) on PDC and L-NAME (100 IJM) 
Induced Constriction in MCAs of Dahi-SS 
Group PDC (%) Lumen (~J.m) Lumen (~J.m) ~Lumen %lumen 
Pre-arginine Post-arginine Diameter constriction in 
Application Application (IJm) response to 
L-NAME 
(I 00 !J.m) in the 
presence of L 
or D-arginine 
L-Arginine 
(81JM) 27.7±3.2 129.7±11.1 131.1 ±3a 1.4±10.5 ob 
(n=4) 
· D-Arginine 
(81JM) 33.1±4.5 127.7±10.4 113.7±5.4 -14.1±9.4 -22.6±3.8 
(n=4) 
Values represent the mean± S.E.M 
a P<0.05 vs Lumen Diameter after Arginine Incubation 
b P<0.05 vs L-Name Response in D-Arginine Group 
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prevent L-NAME action would suggest that the vasoconstriction produced by L-
NAME was in fact being mediated by the inhibition of NOS. 
5.5 DISCUSSION 
MCAs of post-HE Dahi-SS fed 8. 7% NaCI displayed an inability to respond 
to a 100 mmHg pressure step whereas the MCAs from asymptomatic Dahi-SS 
fed 8.7% NaCI for 1 week exhibited robust PDC. The influence of NO and the 
endothelium on basal tone and PDC were assessed in MCAs sampled from 
healthy Dahi-SS fed a normal salt (0.7% NaCI). We observed that endothelial 
removal did not alter the amplitude of PDC in the MCAs but shifted the operating 
range of the lumen diameter changes in response to pressure to a more 
constricted state. This indicated that the endothelium exerted a basal 
vasodilatory influence that modulated PDC. The observation that endothelial 
removal under conditions of NOS inhibition further enhanced vasoconstriction 
suggest1ed that a proportion of the vasodilation produced by the endothelium was 
mediated by a non-NO vasodilator. The ability of the endothelium to release a 
non-NO vasodilator was further supported by the finding that a substantial 
proportion of vasodilation produced by bradykinin in the MCAs was endothelial 
dependemt but not NO mediated. In the absence of endothelium, NOS inhibition 
enhanced MCA constriction indicating that a non-endothelial source of NO 
influencE~d basal tone in the MCAs the sequential removal of the endothelium and 
the total inhibition of NOS and presumably all NO production progressively 
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increase~d basal MCA constriction. In doing so, it limited the further ability of the 
MCAs to constrict in response to pressure and thus reduced the amplitude of 
PDC observed in response to a 100 mmHg pressure step. 
MCAs sampled from Dahi-SS with HE that were fed 8.7% NaCI exhibited 
an attenuated ability to constrict in response to NOS inhibition and to dilate in 
response to bradykinin when compared to arteries sampled from asymptomatic 
Dahi-SS fed 8.7% NaCI or Dahi-SS fed normal salt. This suggested that the 
basal rellease of NO (from endothelial and non-endothelial sources) is reduced 
and that endothelial dependent vasodilation initiated by bradykinin and mediated 
by NO and non-NO vasodilators are compromised in the MCAs of Dahi-SS with 
HE. 
5.5.1 Nitric Oxide and Hypertension Development 
The endothelium plays an important role in regulating cerebrovasculature 
tone through the release of constrictor and vasodilatory factors (Faraci, 1993; 
Faraci ~~ Heistad, 1998) and the impairment of endothelial function plays role in 
hypertension development (Boulanger, 1999). In the present study, the 
cerebrovascular tone in MCAs from Dahi-SS is likely regulated by the release of 
vasodilatory factors from the endothelium. The observation that endothelial 
removal produced a significant decrease in lumen diameter in comparison to 
intact endothelial segments suggests that the endothelium decreases basal tone. 
Despite this increase in basal tone after endothelial removal, the dynamics of the 
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PDC response were not significantly different in endothelial intact segments 
versus denuded segments (see Table 4). This is consistent with previous studies 
in which the removal of the endothelium in a number of different vascular beds 
did not attenuate the PDC response (McCarron et a/., 1989; Kuo et a/., 1990; 
Falcone eta/., 1991). 
Prior to this study, altered NO activity has not been shown in the 
cerebrovascular of Dahi-SS. However, the kidney has shown impaired NO/NOS 
activity (Chen & Sanders, 1993; Chen et a/., 1993). Oral administration of L-
arginine (the biological substrate for NO) reverses salt induced hypertension in 
Dahi-SS rats and NO production is reduced when Dahi-SS (but not Dahi-SR) are 
fed high salt (8% NaCI) (Chen et a/., 1993). Furthermore, Dahi-SS fed high salt 
(8% NaCI) also have lower levels of NOS activity (Hayakawa & Raij, 1998). 
Therefore, it is plausible to suggest that defects in NO generation may play a role 
in hypertension development in Dahi-SS and that such alterations extend to 
multiple vascular beds, which include the cerebrovasculature. 
5.5.2 Endothelium Dependent Vasodilation in MCAs of Dahl-55 
Endothelium-dependent vasodilation is impaired in many models of both 
experimental and human hypertension (Luscher & Vanhoutte, 1986; Panza et a/., 
'1990). This is consistent with the present study in which MCAs of post-HE Dahi-
SS fed high salt exhibited a significant attenuation of vasodilation to bradykinin 
(endothelial-dependent vasodilator) in comparison to MCAs of asymptomatic 
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Dahi-SS fed a high salt diet. In the presence of L-NAME, vasodilation evoked by 
bradykinin was still substantial in MCAs from Dahi-SS fed a high salt diet for 1 
week. Vasodilation to bradykinin observed in MCAs from asymptomatic Dahi-SS 
·in the presence of NOS inhibition with L-NAME suggests that another factor other 
than NO is responsible for vasodilation. 
Vasodilation in response to a number of vasodilators such as 
acetylcholine, have been suggested to be evoked by EDHF (Feletou & 
Vanhoutte, 1988; Dong eta/., 2000; Golding et a/., 2002). There has been much 
debate over the past decade as to the mechanisms underlying EDHF evoked 
vasodilation but a general consensus is that it is mediated by the opening of K+ 
channels (Triggle et a/., 1999; Dong et a/., 2000; Busse et a/., 2002). The 
mechanisms underlying EDHF mediated vasodilation is complex because it is 
dependent on the particular vascular bed of interest (Edwards et a/., 1998; Dong 
eta/., 2000). The additional non-NO vasodilatory factor observed in the present 
study may be EDHF however at the present time sufficient experimental 
evidenc~3 supporting or contradicting the above theories is not available. 
5.6 CONCLUSIONS 
As Dahi-SS develop hypertension in response to high salt feeding there is 
a significant increase in basal tone in the cerebrovasculature of these animals. 
The increased level of basal tone observed in the MCAs of Dahi-SS fed high salt 
could be precipitated by the decreased influence or release of endothelial 
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sources of NO and or non-endothelial vasodilators. The loss of PDC and CBF 
autoregulation observed in Dahi-SS with HE was not produced by an endothelial 
defect since PDC was robust in MCAs of Dahi-SS lacking a functional 
endothelium. The importance of the increased basal tone observed in Dahi-SS 
with HE may be that it acts as a protective mechanism to counteract increases in 
CBF, due to increased BP. This is consistent with the observation that 
hemorrhage formation is rare in these animals following development of HE and 
the characteristics of CBF autoregulation observed in Dahi-SS fed high salt 
. (discussed in Figure 17). 
5. 7 OVERALL SUMMARY OF STUDY 
The overall focus of the present study was to evaluate the Dahi-SS as a 
model for stroke development. Dahi-SS rapidly developed high blood pressure 
when fed a high salt diet (8. 7% NaCI). This was subsequently followed by death 
2.5 wee!ks after the initiation of the diet. Prior to death, Dahi-SS exhibited 
behavioural symptoms, which were thought to be consistent with the 
development of stroke. 
VVe characterized the cerebrovascular pathology of rats exhibiting 
behavioural signs thought to be consistent with stroke. These rats displayed 
significant levels of edema and fluid extravasation indicative of the breakdown in 
the inte~}rity of the blood brain barrier and fluid movement into the extravascular 
space. Brain ischemia was absent and intracerebral hemorrhage was rare. We 
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concludE~d that the behavioural abnormalities observed in Dahi-SS prior to death 
were indicative of hypertensive encephalopathy. This condition occurs during 
hypertension and is associated with the development of seizures, coma, stupor 
and can produce death in humans. It is differentiated from true stroke by the fact 
that it can occur in the absence of cerebral ischemia and hemorrhage. 
Plasma aldosterone was elevated in Dahi-SS with stroke but the levels of 
this hormone were far less than those observed in a high renin-angiotensin 
model of stroke development such as SHRsp. The antihypertensive agent 
(captopril) was ineffective in lowering blood pressure or preventing death. 
Multiple end organ failure was evident prior to death as demonstrated by kidney 
dysfunction characterized by an increase in plasma creatinine, urinary protein 
excretion, and plasma urea nitrogen as well as decreased plasma albumin. 
The ability of Dahi-SS to autoregulate CBF was altered in relation to the 
duration that the rats were fed 8.7% NaCI. After 3 weeks of high salt feeding, 
even asymptomatic Dahi-SS lost the ability to autoregulate CBF. This indicated 
that CBF autoregulation was lost prior to HE development. We subsequently 
assessed PDC in isolated MCAs. Pressure dependent constriction of the 
~erebrovasculature is thought to be an important mechanism involved in 
maintaining CBF autoregulation. Elevations in blood pressure promote 
cerebrovascular vasoconstriction. The latter response increases cerebrovascular 
resistance to flow and counteracts the potential increase in CBF that might be 
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produced by the elevated BP. The net result is that CBF remains constant 
despite the elevation in BP. 
PDC in the MCAs was attenuated in asymptomatic Dahi-SS fed high salt 
for 3 weeks and was totally abolished in rats exhibiting HE. Chronologically, the 
defects iin PDC coincided with the loss of CBF in the MCAs. The characteristics 
of CBF regulation with varying BP and the nature of the changes observed in 
isolated MCAs suggested that CBF autoregulation was lost under conditions 
·consistent with the presence of cerebrovasculature vasoconstriction. This 
alteration could have blunted the potential overperfusion of the 
cerebrovasculature that might have been expected under conditions where CBF 
autoregulation was lost in the presence of hypertension. This may have exerted a 
protective effect, which prevented the progression of HE to the development of 
intracerebral hemorrhage thus accounting for the low incidence of cerebral 
hemorrhage observed in our model. 
The loss of PDC appeared to be coupled with a dysfunctional PKC 
system. Dahi-SS with HE were unable to constrict to PKC activation via phorbol 
esters. Since PKC antagonist's inhibit PDC, it is possible that the absence of 
PDC in the MCAs of Dahi-SS with HE may have been produced by a 
dysfunctional PKC system. There was also an abnormal response to endothelial-
derived vasodilators. MCAs from post-HE Dahi-SS exhibited significantly higher 
levels of basal tone and no response to the endothelial dependent vasodilator, 
bradykinin. The basal production of NO and non-NO endothelial dependent 
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vasodilators and or the actions of these dilators were diminished in Dahi-SS with 
HE. All the latter alterations could contribute to the production of increased basal 
tone in MCAs of Dahi-SS. This abnormal function may have been beneficial. The 
decreased vasodilatory capacity of the cerebral vasculature could have 
increase1d cerebrovasculature under in vivo conditions. In doing so, it might have 
reduced the degree of overperfusion that might have occurred under 
hypertensive conditions, thus retarding the progression of HE to cerebral 
hemorrhage in Dahi-SS. 
A schematic diagram outlining the possible mechanisms promoting the 
development of hypertensive encephalopathy in Dahi-SS is outlined in Figure 25. 
Hypertension development in Dahi-SS is promoted by volume loading (i.e. Na+ 
and water retention) in response to a high salt diet. As the kidney becomes 
damaged, proteinuria and uremia develop. The development of proteinuria 
decreases plasma protein and oncotic pressure. The latter alterations, in 
combination with high hydrostatic pressure, facilitate the movement of fluid into 
the extravascular space, causing HE development (i.e. edema formation). As BP 
increases, PDC (via alterations in PKC activity) and CBF autoregulation becomes 
dysfunctional. This ultimately leads to an overperfusion of the cerebrovasculature 
further enhancing edema formation causing hypertensive encephalopathy 
development. 
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5.8 Future Experimental Directions 
Future studies using the Dahi-SS model of HE should focus on a number 
of key areas that have immerged from the present study. These include further 
analyses of the PKC signal transduction pathway evaluating specific isoform(s) of 
PKC as well as its downstream targets involved in promoting PDC. In addition, 
addressing these questions in light of the development of HE to determine the 
specific nature of PKC dysfunction that is involved in HE development. Changes 
in NO activity, including the contribution of other forms of endothelium dependent 
vasodilators (i.e. EDHF) that may play a role in modulating activity prior to and 
followin~J HE development also need investigation. Further, do alternative pools 
of NO (i.e. smooth muscle) exert any effects on modulating myogenic activity? 
Finally, with the present study being the first to develop a animal model for HE, a 
further investigation how the animal model correlates with the onset of HE in 
humans in terms of pathology and possible treatment of the symptoms observed 
in the animal model. 
The present study clearly demonstrates that PKC activation is involved in 
the pressure dependent constriction response and further; PKC signaling is 
altered following the development of HE. These observations lead us to postulate 
how PKC activation is altered. Using specific antibodies against the various 
isoform(s) of PKC we will be able to determine what isoform is present prior to 
development of HE and further if there is a down regulation of a particular isoform 
followin~1 the development of HE. Secondly, with the recent advancement in 
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selective antagonists of the specific isoforms of PKC we can determine if 
inhibition of particular isoforms of PKC mimic the effects observed with global 
PKC inhibition effects outlined in chapter 4. Of the current 11 isoforms of PKC, 
two candidates have recently been suggested to be involved in promoting 
myogenic activity, PKC-a and PKC-E. Both PKC-a and PKC-E have been 
implicatHd in myogenic contractions of the coronary microcirculation (Dessy et 
a/., 1998; Dessy eta/., 2000). 
In addition to the possible specific isoforms of PKC involved in promoting 
the PDC response in this model evaluation of downstream targets like the TRPc6 
channel described in chapter 4 are worth further investigation. Using 
oligodeoxynucleotide antisense treatment we can determine if inhibition of this 
channel disrupts PDC in MCA's from Dahi-SS to mimic the loss of PDC observed 
in post-HE Dahi-SS. Also, if this is an important target of PKC in generating PDC, 
does the mRNA for the TRPc6 decrease as PDC becomes attenuated during the 
development of HE. 
Although the mechanisms involved in generating PDC are mediated in the 
smooth muscle the endothelium also plays an important role in modulating 
myogenic activity. In the present study two interesting observations were noted. 
These were that there was an endothelium dependent vasodilation present in the 
presenCie of NOS inhibition and also that constriction to NOS was present in 
vessels in which the endothelium was removed. 
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The first observation suggests the presence of a non-NO dilatory 
substance. As outlined in Chapter 5 the likely candidate is EDHF. EDHF is 
interesting as the specific mechanism underlying its activation remains to be 
elucidated. According to a recent review article evidence exists for three possible 
mechanisms, (i) the activation of the cytochrome p450 pathway, (ii) endothelial 
cell hyperpolarization that is transmitted to the smooth muscle via gap junctions 
and (iii) endothelial released K+ that acts on smooth muscle potassium channels 
or activates Na+-K+-ATPase inducing smooth muscle hyperpolarization (Busse et 
a/., 2002). The initiation of these mechanisms all requires endothelial K+ channels 
activation prior to EDHF release. Located on endothelial cells are three main K+ 
channel:s that are classified on their conductance states. These include small 
conductance channels (sK), intermediate conductance channels (iK) or large 
conductance channels (BK) Busse eta/., 2002). 
To determine if the observed dilation to bradykinin in the presence of NOS 
inhibition was mediated via EDHF the classical experiment is the selective 
inhibition of both the iK (apamin) and sK (charybdotoxin) channels. If EDHF is the 
residual dilatory component released in the MCAs of Dahi-SS, the selective 
inhibition of these K+ channels will inhibit the remainder of the dilatory component 
to bradykinin that is insensitive to NOS inhibition. If there is an EDHF component, 
the seleetive inhibition of cyotochrome p450 with 17 -ODYA or gap junction 
inhibitors (GAP 27) will further our knowledge as to the specific mechanisms that 
EDHF may be mediated through in promoting vasodilation in MCAs from Dahi-
SS. 
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The observation that NOS inhibition with L-NAME still evoked a 
vasoconstriction in MCAs in which the endothelial had been removed suggests 
the involvement of a non-endothelial source of NO. In order to evaluate this in 
our model, cross sections of MCA's could be stained nitric oxide. This will 
determine where pools of NO are located within these vessels. Also, if this 
particular pool of NO is important, does this pool become reduced in response to 
HE development. 
Finally, this is the first animal model of HE and further investigation into 
what pre!cipitates its onset it needed. Based on the observations in present study 
Dahi-SS undergo a rapid elevation in BP following the feeding of a high salt diet 
whereas Dahi-SR does not. In humans, patients who exhibit signs of HE treated 
by reducing the hypertension which restores normal cerebral blood 
autoregulation and stops on the developing edema formation. In order to 
substantiate this model and a viable model for HE we have to demonstrate that a 
reduction in BP abrogates the onset of HE in these animals. However 
conventional antihypertensive treatments using ACEis and AT1 receptor 
antagonists (losartan) failed to reduce the BP or the onset of HE in this model. 
Therefore, in future experiments, new anthypertensive treatments are required to 
try and reduce the BP in Dahi-SS fed high salt and retard the onset of HE. One 
such treatment might be through the use of diuretics like hydralazine. Since, the 
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hypertension observed in this model is via volume overload maybe the use of 
diuretics could lower BP reverse the effects of HE development. A corollary 
experiment would be to induce high BP in Dahi-SR to determine if the raising of 
BP in these animals mimics the HE symptoms observed in Dahi-SS or if the 
raising of BP not the precipitating factor but is through a yet unknown mechanism 
that is unique to Dahi-SS that predisposes them for the development of HE. 
Overall, by further investigating the underlying mechanisms at the level of 
the smooth muscle and endothelium that become dysfunctional in response to 
HE devE~Iopment along with the global precipitating mechanisms (i.e. increases in 
BP) our understanding of the first animal model of HE will be furthered. Untimely 
will help understand the onset of HE in humans leading to better prevention and 
treatment paradigms. 
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